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ABSTRACT 
Chronic hypoxia (CH)-induced pulmonary hypertension (PH) is associated with 
diminished ATP-induced endothelial Ca2+ entry as well as membrane cholesterol in 
pulmonary arteries. Store-operated Ca2+ entry (SOCE) and depolarization-induced Ca2+ 
entry are major components of the response to ATP and are similarly decreased after CH. 
Because endothelium-dependent vasodilation is closely associated with pulmonary 
endothelial [Ca2+]i, the blunted agonist-induced Ca
2+ influx in pulmonary artery endothelial 
cells (PAEC) may contribute to the development of CH-induced PH. Interestingly, 
impaired agonist-induced Ca2+ influx in PAEC following CH can be restored by membrane 
cholesterol supplementation. In the current studies, we hypothesized that impaired Ca2+ 
entry in PAEC following CH is due to decreased membrane cholesterol. 
We demonstrated that substitution of cholesterol with its functionally inactive epimer 
epicholesterol, greatly attenuated ATP-induced Ca2+ influx in PAEC from control rats. 
Whereas epicholesterol similarly blunted endothelial SOCE in PAEC from both groups, 
cholesterol supplementation restored diminished SOCE in PAEC from CH rats while 
having no effect in controls. Similar effects of cholesterol manipulation on T-type Ca2+ 
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channel-mediated Ca2+ influx were observed in PAEC. Additionally, the role of cholesterol 
in SOCE mediated by Orai1, a Ca2+ selective ion channel, was examined in PAEC. 
Whereas cholesterol restored endothelial SOCE in CH rats, both epicholesterol and the 
Orai1 inhibitor, AnCoA4, attenuated SOCE only in normoxic controls. The Orai1 inhibitor 
had no further effect in cells pretreated with epicholesterol. In cultured pulmonary 
endothelial cells, using pharmacological inhibition and siRNA knockdown of Orai1, we 
found that epicholesterol, AnCoA4 and Orai1 siRNA each inhibited SOCE compared to 
their respective controls.  Epicholesterol had no additional effect following knockdown of 
Orai1. Finally, we found that endothelial stromal interaction molecule 1 (STIM1)-Orai1 
interaction, which is essential for SOCE, requires membrane cholesterol. Our studies 
support a novel regulatory role for membrane cholesterol in agonist-induced Ca2+ entry and 
its components. Our observation also demonstrated that altered membrane cholesterol 
homeostasis may contribute to impaired endothelial Ca2+ influx pathways following CH. 
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CHAPTER 1: Introduction 
Mechanisms of chronic hypoxia-induced pulmonary hypertension 
Pulmonary hypertension (PH) is the elevation of blood pressure in the pulmonary 
circulation and is a leading cause of morbidity and mortality in patients with a number of 
cardiovascular and respiratory diseases. Human PH is clinically defined as a mean arterial 
pressure ≥ 25 mmHg at rest (74). Multiple factors may lead to the development of PH, 
including genetic defects, disease, or environmental exposure. Interestingly, persistent or 
intermittent hypoxia is highly associated with many forms of PH, such as in chronic 
obstructive pulmonary disease, interstitial lung disease, and obstructive sleep apnea (65, 
96, 138). The chronic hypoxia (CH)-induced PH animal model is one of the most 
commonly used to mimic human disease (165). 
Under normal conditions, the pulmonary circulation is a low-resistance and low-
pressure system. These characteristics allow blood to easily travel from the right ventricle 
through the lungs for gas exchange. Pulmonary vascular resistance (R) can be calculated 
as the ratio of the pressure gradient (∆P) across all vessels to flow (Q):  
R = ∆P / Q 
Thus, increased pulmonary arterial resistance would lead to elevated pulmonary arterial 
pressure that must be overcome by the right heart to pump blood through pulmonary 
circulation. There are various factors that can influence vascular resistance. Assuming a 
vascular system consists of straight, non-distensible cylindrical tubes that have laminar 
flow, then vascular resistance R of a single tube is equal to the product of the length of the 
tube (l) and viscosity (η) and a constant divided by the product of π and the fourth power 
of the internal radius: 
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R = (l * η *8) / (π *r4) 
This is known as the Hagen-Poiseuille’s law. Under pathological conditions such as 
prolonged exposure to hypoxia, however, there are functional and structural changes in the 
pulmonary circulation, including polycythemia, acute hypoxia-induced vasoconstriction of 
small pulmonary arteries, and pulmonary arterial remodeling with medial hypertrophy (2, 
60). According to Hagen-Poiseuille’s law, all of these changes lead to increase in 
pulmonary vascular resistance. 
Polycythemia, an increase in the volume percentage of circulating red bloods cells 
in whole blood, results in increased in blood viscosity, thereby increasing vascular 
resistance.  Chronic exposure to hypoxia may activate hypoxia inducible factor (HIF)-1α 
which induces erythropoiesis that leads to the polycythemic response (34). CH-induced 
active pulmonary vasoconstriction and arterial remodeling are the consequences of several 
complex physiological mechanisms. One major cause of these changes to the pulmonary 
vasculature is pulmonary arterial endothelial dysfunction, which is usually observed in the 
development of PH (10; 35). The dysfunction of endothelial cells may be triggered by 
multiple sources: shear stress, inflammation, hypoxia, and other unknown factors. This 
impaired endothelial function is generally believed to result in imbalanced production of 
various vasoactive factors (20, 49, 153). The increased production of vasoconstrictors with 
decreased production of vasodilators is common in most forms of PH. Although the 
pulmonary endothelium plays a major role in PH, the mechanisms by which impaired 
endothelial function leads to the development of PH are not well defined. Understanding 
the mechanisms of endothelial dysfunction leading to and contributing to PH is central to 
designing effective and specific treatment for these pathologies. 
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Endothelium in the pulmonary circulation 
The vascular endothelium is the innermost layer of blood vessels and serves as a 
semi-selective barrier that allows exchange of fluid and macromolecules between the 
circulation and surrounding tissues. As a major part of the vascular system, the endothelium 
plays a crucial role in several physiological activities, such as maintaining tissue-fluid 
homeostasis, regulating angiogenesis and vascular tone, and preventing inflammation (54, 
75, 107, 125, 139). In the pulmonary circulation, endothelial cells help maintain low 
resistance and prevent proliferation/migration of smooth muscle cells.  
Pulmonary endothelial cells regulate vascular tone by the balanced production of 
various vasoactive compounds. Vascular tone reflects the result of smooth muscle 
contraction due to phosphorylation of myosin light chain (MLC). MLC phosphorylation is 
generally regulated by Ca2+-dependent and -independent pathways: activation of myosin 
light chain kinase via Ca2+/calmodulin or inhibition of myosin light chain phosphatase 
through activated small GTPase RhoA and Rho-associated protein kinase (15). 
Endothelium can produce vasoconstrictors like endothelin-1 and thromboxane that act as 
paracrine factors to stimulate G protein-coupled receptors and cause Ca2+ influx and 
subsequent contraction of smooth muscle cells (37, 131, 160). On the other hand, the 
pulmonary endothelium also releases vasodilators such as nitric oxide and prostacyclin in 
response to shear stress and agonist stimulation (52, 68). These vasodilators decrease both 
intracellular Ca2+ levels and Ca2+ sensitivity of smooth muscle cells, thereby causing 
vasorelaxation (86, 93). 
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NO is the most well studied vasodilator and plays an important role in maintaining 
low resistance in the pulmonary circulation (137). NO causes vasodilation primarily 
through activation of soluble guanylyl cyclase (cGC) in pulmonary artery smooth muscle 
cells (PASMC) (93), which leads to the production of cGMP from GTP. cGMP then 
activates protein kinase G (PKG). Intracellular calcium levels ([Ca2+]i) are crucial for 
myosin light chain (MLC) phosphorylation and contraction in PASMC. PKG activation 
causes smooth muscle relaxation primarily through lowering [Ca2+]i via various 
mechanisms including inhibition of IP3 receptors (129), activation of sarco/endoplasmic 
reticulum Ca2+-ATPase (SERCA) (93, 123), or activation of plasma membrane Ca2+-
ATPase (113). Stimulated PKG may also lead to activation of Ca2+ -dependent K+ channels 
(BKCa) and PASMC hyperpolarization (5, 40, 46, 167), which inhibits voltage-gated Ca
2+ 
channel (VGCC) -mediated Ca2+ influx and promotes MLC dephosphorylation and 
subsequent vasorelaxation. cGMP may also inhibit calcium channels like TRPCs and 
VGCC thereby causing vasorelaxation. PKG activation also leads to vasorelaxation 
through Ca2+-independent mechanisms. Studies suggest that PKG activates MLC 
phosphatase, which inhibits MLC phosphorylation and subsequent contraction (78, 97). 
PKG may also phosphorylate RhoA, thereby inhibiting RhoA-mediated Ca2+ sensitization 
(16, 17, 127). In addition, NO could directly activate BKCa and potentially cause smooth 
muscle relaxation independent of PKG (15). Besides its role in regulating vascular tone, 
endothelium-derived NO is also known to inhibit smooth muscle cell (SMC) proliferation 
and migration (62, 126), which is important in preventing vascular remodeling in responses 
to stimuli such as inflammation, oxidative stress and apoptosis.  
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Production of many endothelium-dependent vasoactive substances as well as 
regulation of membrane potential are largely a function of pulmonary endothelial [Ca2+]i 
(1). The production of NO, for example, is catalyzed by endothelial nitric oxide synthase 
(eNOS) in the endothelium. Activation of eNOS requires increased endothelial [Ca2+]i and 
formation of a Ca2+/calmodulin complex (89). Along with other cofactors like NADPH and 
BH4, eNOS converts L-arginine into NO and L-citrulline (26, 89). Similarly, production 
of endothelium-derived prostacyclin requires intracellular Ca2+ and calmodulin (89, 130). 
The activation of cytosolic phospholipase A2, the key enzyme to release arachidonic acid 
from plasma membrane, is Ca2+-dependent. Once arachidonic acid is liberated, it could be 
enzymatically converted by cyclooxygenase-1 to prostacyclin after multiple reactions. 
Arachidonic acid is also substrate for production of vasoconstrictor metabolites, such as 
thromboxanes, leukotrienes, and epoxyeicosatrienoic acids. 
 
Regulation of endothelial Ca2+ levels 
Endothelial Ca2+ is important second messenger in various signaling cascades and 
is carefully regulated by complex and dynamic pathways. Endothelial [Ca2+]i reflects the 
sum of Ca2+ influx from extracellular space, Ca2+ release and sequestration by intracellular 
stores, and Ca2+ extrusion from the cell. Endothelial Ca2+ influx is mainly mediated by 
three mechanisms: 1) Ca2+ entry via receptor-mediated cation channels; 2) Ca2+ leak 
through cation channels down its electrochemical gradient; and 3) Ca2+ entry via stretch-
activated cation channels. Steady-state [Ca2+]i may be rapidly altered by stimuli such as 
shear stress or agonists, which activate membrane-bound receptors and cation channels and 
leads to Ca2+ entry (3, 161). This major Ca2+ influx signaling cascade also generates the 
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second messenger, IP3, which can activate downstream ionotropic IP3 receptors on the 
membrane of the ER, causing rapid and transient release of internal Ca2+ stores. Once  ER 
Ca2+ stores are depleted, the ATPase pump refills the intracellular Ca2+ pool by 
sequestering Ca2+ from the cytosol, which may also be facilitated by a Ca2+ leak through 
cation channels on the plasma membrane (1). Meanwhile, the Na+- Ca2+ exchanger on the 
plasma membrane helps remove excessive intracellular Ca2+ after agonist stimulation (23, 
39, 122). Overall, these pathways work together to maintain [Ca2+]i homeostasis in 
endothelial cells. 
 
Agonist-induced Ca2+ entry 
Receptor-mediated Ca2+ influx is one of the major pathways leading to increased 
[Ca2+]i. The binding of an agonist to its receptor mediates the activation of phospholipase 
C (PLC), which then leads to the production of diacylglycerol and IP3 from hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) (11). Cytosolic IP3 then binds to IP3 receptors 
on the membrane of the ER and causes Ca2+ efflux from the ER store. The depletion of ER 
stores triggers Ca2+ influx across the plasma membrane, which is known as store-operated 
Ca2+ entry (SOCE) (150). Agonist binding may also elicit Ca2+ entry through channels that 
are not activated by store emptying. This is known as receptor-operated calcium entry 
(ROCE) (120).  
ATP, as one of the important agonists that meditates endothelial [Ca2+]i, serves as 
a regulator of vascular tone. Studies found that red blood cells (RBCs) and endothelial cells 
(ECs) can release ATP under certain conditions to maintain blood flow. In RBCs, when 
acutely exposed to low PO2, low pH, or mechanical deformation, there is an increase of 
7 
 
ATP release (38, 92, 136). ATP then causes endothelium-dependent vasorelaxation in 
various species and tissues (25). It is likely that RBC- produced ATP binds to purinergic 
receptors on ECs and stimulates NO production (84). In endothelial cells, shear stress 
induces the production of ATP, which serves as an autocrine factor and stimulates 
endothelial NO production (4, 69). It is proposed that extracellular ATP binds to P2Y 
purinergic receptors on plasma membrane of ECs, which leads to IP3 production, internal 
Ca2+ store release, Ca2+ influx and subsequent increase in [Ca2+]i, leading to increased 
eNOS activation and NO production (50). Additionally, ATP may also enhance endothelial 
cell barrier function by Rac and cortactin-dependent activation of the cytoskeleton (59). 
 
Store-operated Ca2+ entry 
SOCE is a Ca2+ influx response when internal SR/ER Ca2+ stores are depleted. 
Under physiological conditions, agonists may bind to transmembrane receptors and 
activate PLC to produce IP3 from hydrolysis of PIP2. IP3 then activates IP3 receptors on 
membrane of SR/ER, leading to Ca2+ efflux, depletion of intracellular Ca2+ stores, and 
activation of cation channels on the plasma membrane (150). SOCE was first proposed in 
1986 by Putney and colleagues and was later found in many cell types. In rat parotid acinar 
cells, the intracellular Ca2+ store depletion by muscarinic-cholinergic agonists causes Ca2+ 
influx (144). If the intracellular Ca2+ store is depleted independent of activation of PLC, 
Ca2+ influx is still observed (143). Later in mast cells, in response to IP3 -induced Ca
2+ 
store depletion, a highly Ca2+ selective inwardly rectifying current was found (57).  This 
store-operated current (Isoc) with a high Ca
2+ selectivity is known as calcium release -
activated calcium (CRAC) current or Icrac.  
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SOCE has been demonstrated to be present in virtually all excitable and non-
excitable cells and is involved in mediating many important physiological activities such 
as neurotransmitter secretion, skeletal muscle contraction, lymphocyte activation, and 
vascular tone (41, 79, 110, 146). Although the physiological importance of SOCE has been 
recognized for some time, the molecular mechanism of SOCE remained unclear until 
recent years. A key finding was the identification of stromal interacting molecule (STIM) 
proteins on the membrane of the ER. STIM1, as one isoform of STIM, was first found in a 
library screen which was developed to identify molecules in stromal cells that bind to pre-
B lymphocytes (98). However, the role of STIM as the molecular component of SOCE was 
revealed more recently through RNA interference (RNAi) screens by two independent 
groups (83, 119). In Drosophila S2 cells, RNAi-mediated knockdown of STIM causes 
significantly reduction of Ca2+ entry induced by the SERCA inhibitor, thapsigargin (TG) 
(119). Similar observation that STIM1 and STIM2 are required for agonist- and TG- 
induced SOCE was found in human HeLa cell (83). Later, continued genome-wide RNAi 
screens in Drosophila S2 cells revealed Orai proteins as key components of the CRAC 
channel (111, 156, 164). The presence of STIM1 and Orai1 are sufficient to reconstitute 
functional SOCE in HEK293 cells (134).  
The exploration for other potential components of SOCE also identified the 
involvement of non-selective Ca2+ -permeable mammalian transient receptor potential 
canocical (TRPC) channels (155). All TRPC channels are activated via the PLC signaling 
pathway (155). However, only TRPC1, TRPC3, and TRPC4 are activated mostly by store 
depletion, whereas the activation TPRC2, TRPC5, TRPC6, and TRPC7 is mainly through 
store-independent mechanisms (155). The finding that STIM1 also gates TPRC1 in SOCE 
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(58) generates a new question in regard to the role of TRPC1 and Orai1 in SOCE. Later 
studies then demonstrated that activation of TRPC1/STIM1-mediated SOCE requires 
functional Orai1 (67, 73). In PAEC, TRPC1 and TRPC4 also form heteromultimeric 
channels and interact with Orai1 via protein 4.1 in caveolin-rich membrane fractions (32). 
This TRPC1/4 complex and Orai1 interaction is important for channel activation and 
calcium selectivity (32). With the identification of these key components of SOCE, the 
molecular mechanism of SOCE is better understood (27). The EF-hand motif in the N 
terminus of STIM1 is localized in the ER lumen and senses ER Ca2+ stores. Upon the 
depletion of the ER Ca2+ store, the SAM domain near the EF-hand motif mediates STIM1 
oligomerization and leads to translocation of STIM1 to the plasma membrane. This 
conformational change of STIM1 allows its interaction with Orai1 and forms ER-PM 
junctions, which are crucial in Ca2+ release-activated Ca2+ influx. 
SOCE in both SMC and ECs is important in regulating vascular tone. In vascular 
SMC, Ca2+ influx induced by SR Ca2+ store depletion via SR Ca2+ -ATPase inhibition is 
associated with increased vascular tone in different blood vessels (79). Interestingly, 
SOCE-mediated vascular tone shows varying sensitivity to voltage-gated Ca2+ channel 
inhibitors between vascular beds. For example, most of the SOCE -induced contraction is 
nifedipine-sensitive in the rat aorta, which is not found in the rat pulmonary artery (79). 
These observations suggest that SOCE may modulate vascular tone in a direct or indirect 
manner. Many studies also indicate that increased [Ca2+]i through SOCE contributes to 
smooth muscle proliferation and migration (13, 108, 141, 142). In cultured proliferative 
migratory rat aortic VSMCs, both SOCE and expression of STIM1 and Orai1 are elevated 
compared with non-proliferative controls (108). Knocking down STIM1 and Orai1 greatly 
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inhibits proliferation and migration of these active VSMCs (108). Besides its role in 
mediating vascular endothelial permeability (147), endothelial SOCE, as part of agonist-
induced Ca2+ entry, significantly contributes to the increase in [Ca2+]i and subsequent 
release of vasodilators like NO and prostacyclin (1, 70, 77, 82). In fact, pharmacological 
inhibition of SOC by SKF-96365 blunts the shear stress-induced NO response (4). 
Endothelial TRPC4 knockdown also impairs agonist-induced vasodilation by reducing 
SOCE (44).  
 
Depolarization-induced Ca2+ entry 
VGCCs are a group of Ca2+ permeable channels that are activated by depolarized 
membrane potential. Based on the requirement of a different level of depolarization for 
activation, these channels can be classified into two major groups, high voltage-activated 
(L-, P/Q-, N-, R- type) and low voltage-activated (T-type) calcium channels (150). These 
channels have been found in neurons, muscle, endocrine cells, and many other cell types 
(29, 145, 150, 162). They are involved in many different physiological activities including 
muscle contraction, excitation of neurons, upregulation of gene expression, release of 
hormones or neurotransmitters (28).  
L-type VGCC were first described in neurons and cardiac cells and later found 
widely expressed in all excitable and some non-excitable cells (152). Ca2+  influx through 
L-type VGCC is the major source of Ca2+ entry in cardiac, skeletal, and smooth muscles. 
In cardiac muscle, activation of L-type VGCC is required to initiate Ca2+-induced Ca2+ 
release and subsequent muscle contraction (14). In skeletal muscle, although L-type VGCC 
are not involved in the initiation of muscle contraction, they are important in mediating 
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Ca2+ release from intracellular stores, which then facilitates mobilization of the 
myofilaments and contraction (117). In vascular smooth muscle cells, Ca2+ influx through 
L-type VGCC also serves as one of the Ca2+ sources for Ca2+/calmodulin-dependent 
phosphorylation of MLC, which leads to smooth muscle contraction. Indeed, L-type 
VGCC are important in mediating blood pressure and myogenic tone (35, 92).  
Although L-type VGCC are considered the major VGCC that regulate the 
myogenic response, T-type VGCC in vascular smooth muscle cells are receiving more 
attention in recent years. In small resistance vessels, T-type VGCC are involved in 
regulating vascular tone (154). T-type VGCC are also involved in the development of CH-
induced PH. Either chronic treatment of a T-type VGCC inhibitor or global deletion of the 
T-type VGCC gene (Cav3.1) protects mice from developing CH-induced PH (30).  
T-type VGCC are normally found expressed in electrically excitable cells. 
However, their expression has also been described in pulmonary microvascular endothelial 
cells and PAEC from rats and mice (101, 157, 159, 166). In PMVECs, Wu et al (159) 
observed voltage-dependent currents with a more depolarized window current when 
compared to typical T-type channels. These currents were sensitive to pharmacological T-
type channel blockers. Wang et al (157) found that acute hypoxia induced membrane 
depolarization and a subsequent increase of endothelial [Ca2+]i in both alveolar capillaries 
and upstream arterioles. The endothelial [Ca2+]i response to acute hypoxia was inhibited 
by the T-type channel blocker mibefradil in both pulmonary capillaries and arterioles. They 
proposed that membrane depolarization induced by acute hypoxia in lung capillaries is 
conducted upstream to arterioles via gap junctions and activates T-type channels. Increased 
endothelial [Ca2+]i then leads to vasoconstriction by activation of Ca
2+-dependent 
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phospholipase A2-mediated vasoconstrictor production. Although T-type VGCC are not 
found in cultured rat PAEC (159), their expression and function have been described in 
freshly dispersed rat PACEs (101). Paffett et al. (101) have shown that T-type VGCCs 
contribute to depolarization-induced Ca2+ entry and ATP-induced Ca2+ entry. These 
findings suggest that T-type VGCCs are important mediators of depolarization-induced 
Ca2+ entry in the pulmonary endothelium. 
 
Impaired pulmonary endothelial Ca2+ influx following CH 
Impaired NO release is often observed in diseases such as chronic obstructive 
pulmonary disease and congestive heart failure and is a key feature of pulmonary 
hypertension (8, 90, 115, 140, 148). However, eNOS protein expression is increased in 
pulmonary hypertensive patients and CH-induced pulmonary hypertensive rats (48, 51, 
116).  The controversial observation that increased eNOS protein expression and impaired 
endothelium-derived vasorelaxation simultaneously occur in CH-induced PH rats could be 
the result of blunted eNOS activity. Murata et al confirmed this assumption by reporting 
that CH impairs posttranslational regulation of eNOS activity via blunting agonist-induced 
Ca2+ influx (95).  
Previous work from our laboratory also shows that both basal [Ca2+] i and agonist-
induced Ca2+ influx are lower in PAEC from CH rats compared to those of control animals 
(99, 100). CH similarly inhibits endothelial SOCE and depolarization-induced Ca2+ influx 
through T-type VGCC, which are major components of agonist-induced Ca2+ entry in 
isolated PAEC (99, 101). These findings suggest that store-operated channels and T-type 
VGCC are important mediators of ATP-induced Ca2+ entry and that impaired Ca2+ entry 
and may contribute to reduced basal [Ca2+]i in PAEC after CH, which may lead to 
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dysfunction of posttranslational eNOS regulation and subsequent impairment of 
endothelium-derived NO production in CH-induced PH. 
 
Membrane cholesterol 
Cholesterol is a major component of the plasma membrane. The importance of 
membrane cholesterol has been shown in regulating neurotransmission, cell signaling, and 
protein sorting (85, 128, 132). Additionally, many diseases such as type II diabetes (31), 
Alzheimer’s disease (6), and cancer (91) are associated with abnormal cellular cholesterol 
levels. The homeostasis of cellular cholesterol levels is maintained mainly by four 
pathways: cellular cholesterol synthesis, cholesterol uptake from extracellular sources, 
cholesterol efflux, and esterification and storage in the lipid droplets (31). The ER is the 
major site of cholesterol de novo synthesis, which requires multiple enzymes and cofactors 
to covert acetyl-CoA to cholesterol in a complex series of reactions. Once synthesized, 
cholesterol is bound with caveolins and transported from the ER to plasma membrane. 
More than 90% of free cholesterol is located in the plasma membrane (66, 76) and is 
distributed to microdomains known as lipid rafts, which are rich in cholesterol, 
sphingolipids, and various proteins. Once in the plasma membrane, cholesterol maintains 
membrane integrity and regulates many signaling pathways. 
Membrane cholesterol also serves as an important structural component of the 
plasma membrane by regulating membrane fluidity and permeability. Cholesterol may help 
maintains membrane fluidity by interfering with the interactions between phospholipid 
fatty acid chains. However, cholesterol may also increase membrane rigidity by reducing 
the flexibility of phospholipid fatty acid chains (55). This regulation of membrane fluidity 
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is crucial in controlling solute movement across the membrane when membrane 
composition or temperature are altered. In addition, positive electrostatic potential in the 
plasma membrane is increased when cholesterol content is augmented, which may change 
the membrane composition of charged components and alter the permeability of cations 
and anions (55). Membrane cholesterol is also required for the formation of specific lipid 
rafts known as caveolae. Caveolae are flask-shape invaginations of the plasma membrane 
that contain caveolin, cholesterol, sphingolipid, and various signaling molecules and 
receptors. They are involved in endocytosis, cholesterol transport, and signal transduction 
(42, 106). Besides caveolins, which serve as the structural component of caveolae (36, 112, 
114), cholesterol is also essential in maintaining stable and functional caveolae. Both 
inhibition of cholesterol synthesis and acute membrane cholesterol depletion lead to 
caveolar disruption and inhibition of cell signaling (64, 94, 105, 124, 168). 
 
Membrane cholesterol regulates ion channel function 
Besides its structural role, membrane cholesterol is also important in regulating 
membrane-bound protein structure and function. Cholesterol is a polycyclic amphipathic 
molecule with a polar section consisting of a single β-hydroxyl group which can interact 
with membrane lipids or proteins through formation of hydrogen bonds (105). Various 
membrane-bound proteins have been shown to be regulated by membrane cholesterol, such 
as receptors, transporters, peptides, and ion channels (56, 80, 102, 151, 163).  
The effect of membrane cholesterol on ion channel function may vary depending 
on the type of ion channel. Many studies demonstrate an inhibitory role of membrane 
cholesterol on ion channel activity via decreased open probability, unitary conductance, 
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and the number of active channels (80). For example, cholesterol decreases the open 
probability of many K+ channels, as well as voltage-gated Na+ and Ca2+ channels (33, 81, 
149). In contrast, other ion channels such as nicotinic acetylcholine receptor, GABAA 
receptors, epithelial Na+ channels and TRPC channels are inhibited by removal of 
membrane cholesterol (7, 9, 10, 72, 135), indicating that cholesterol may have an essential 
functional role in regulating these channels.  
Cholesterol may additionally modulate the function of membrane proteins via 
either direct interaction or through altering the properties of lipid microdomains (80). 
Direct interaction between sterols and ion channels has been suggested by the sensitivity 
of inwardly rectifying potassium (Kir) channels (118) and large conductance, Ca
2+-
activated potassium (BKCa) channels (24) to various sterol analogues. In addition, 
cholesterol binding regions exist in both Kir channels and BKCa channels (121, 133). 
Meanwhile, cholesterol may also indirectly regulate ion channels by modulating bilayer 
stiffness and hydrophobic interaction between the membrane proteins and the lipid bilayer 
(9). Thus, when determining the role of membrane cholesterol on channel function, 
extreme caution is needed to discriminate the different mechanisms by which cholesterol 
regulates certain types of ion channels. The enantiomer of cholesterol, epicholesterol, 
differs from cholesterol only in the stereochemistry of the hydroxyl group and has similar 
effects on membrane fluidity and lipid domain formation as those of cholesterol, but lacks 
the regulatory influences of cholesterol on membrane proteins (80). Thus epicholesterol 
has been used as a tool to distinguish the direct and indirect effect of cholesterol (80).  
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Membrane cholesterol regulates Ca2+ influx 
The importance of membrane cholesterol in regulating Ca2+ entry has been shown 
in many different types of cells. In VSMCs, membrane cholesterol depletion by methyl-β-
cyclodextrin reduces TRPC1-mediated Ca2+ entry in response to endothelin-1 (9). 
Similarly, cholesterol depletion decreases STIM1 clustering, prevents activation of 
TRPC1, and blunts SOCE in HSG and HEK293 cells (9). In addition, depletion of 
membrane cholesterol also disrupts the association of Orai1 with TRPC1 and STIM1, and 
attenuates SOCE in human platelets (61). This observation is also confirmed in 
lymphocytes, in which a reduction of membrane cholesterol decreases SOCE. Cholesterol 
enrichment, on the other hand,  increases agonist-induced Ca2+ influx in cultured VSMCs 
(12).  
Under pathological conditions, the importance of membrane cholesterol in 
regulating endothelial Ca2+ influx has also been revealed. Our laboratory’s previous studies 
show that both membrane cholesterol levels and ATP- induced Ca2+ entry are reduced in 
PAEC following CH (100).  Interestingly, cholesterol repletion restores CH-impaired 
endothelial ATP- induced Ca2+ influx  (100), suggesting that membrane cholesterol may 
facilitate endothelial agonist-induced Ca2+ entry. In PAEC, ATP induces both SOCE and 
T-type VGCC blocker-sensitive Ca2+ influx (101).  Although the role of membrane 
cholesterol in regulating SOCE has been implicated in many studies (10, 47), the effect of 
membrane cholesterol in regulation of endothelial depolarization-induced Ca2+ entry is 
unknown. Considering that SOCE and depolarization-induced Ca2+ entry are major 
components of ATP-induced Ca2+ entry, and that both Ca2+ influx pathways are blunted 
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following CH (99, 101), it is possible that membrane cholesterol also regulates these two 
components of the ATP-induced Ca2+ response. 
 
Rationale and specific aims 
As summarized above, endothelial dysfunction is closely associated with many forms 
of PH. In CH-induced PH, for example, increased pulmonary vascular resistance and 
myogenic tone are observed with decreased production of endothelial vasodilatory factors 
(21, 63, 95, 158). [Ca2+]i is a key regulator of the synthesis of many endothelial vasoactive 
factors. CH decreases [Ca2+]i by impairing Ca
2+ influx in pulmonary artery endothelium 
(99–101). Diminished endothelial Ca2+ entry may contribute to elevated vascular tone by 
limiting the activity of eNOS and other Ca2+ -sensitive vasodilatory pathways (26, 43, 53, 
87, 88, 95). Many Ca2+ channels are localized in cholesterol-enriched lipid rafts (19, 45, 94, 
104). Cellular cholesterol homeostasis affects membrane lipid content and thus the function 
of Ca2+ channels and subsequent signaling pathways (10, 18, 22, 103, 109) by mechanisms 
that are not fully understood. 
There are multiple Ca2+ entry pathways that could directly affect intracellular Ca2+ 
levels in the endothelium. Agonist-induced calcium entry, as one of the major Ca2+ entry 
pathways, has several components including SOCE and receptor-operated Ca2+ entry 
(ROCE). Studies from our laboratory have shown that both endothelial SOCE and ROCE 
are reduced in CH-induced PH (99, 101). Our previous work also identified a membrane 
potential-sensitive Ca2+ entry pathway, which contributes to ROCE under control 
conditions, but is lacking in CH-induced PH (101). This depolarization-induced Ca2+ entry 
appears to involve T-type VGCCs which are expressed mesenteric and cerebral 
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endothelium but not reported in endothelium from other systemic vascular beds (71). 
Additionally, CH leads to diminished membrane cholesterol that can be restored by 
cholesterol supplementation (100). Interestingly, impaired agonist-induced Ca2+ entry is 
also rescued by cholesterol restoration (100). However, it is not clear if membrane 
cholesterol affects different Ca2+ entry pathways similarly. Furthermore, it is unknown 
whether the effect of membrane cholesterol on Ca2+ entry is due to altered interaction of 
channels with cholesterol directly or with other factors. Understanding the effect of CH on 
cholesterol homeostasis and its impact on endothelial function may lead to new treatment 
strategies for PH. Therefore, the proposed studies will test the central hypothesis (Figure 
1) that impaired Ca2+ entry in pulmonary artery endothelial cells following chronic 
hypoxia is due to decreased membrane cholesterol.  
To test this hypothesis, we addressed the following Specific Aims: 
Specific Aim 1: Determine the role of membrane cholesterol homeostasis in 
impaired pulmonary endothelial Ca2+ entry following CH (Figure 2).  
We hypothesized that 1) membrane cholesterol facilitates SOCE and depolarization-
induced Ca2+ entry in PAEC; and 2) reduced endothelial Ca2+ influx following CH is due 
to loss of membrane cholesterol. To test these hypotheses, we administered cholesterol or 
epicholesterol to acutely isolated PAEC from control and CH (4 wk, 380 Torr) rats to either 
supplement or replace native cholesterol, respectively. The efficacy of membrane 
cholesterol manipulation was confirmed by filipin staining. Ca2+ influx in PAEC was 
measured in response to ATP, store-depletion, or a depolarizing stimulus. Additional 
experiments examined the effect of cholesterol manipulation on endothelial caveolar 
number in cultured pulmonary endothelial cells. 
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Specific Aim 2: Identify the contribution of membrane cholesterol to regulation 
of Orai1-mediated SOCE in pulmonary endothelial cells (Figure 3).  
We hypothesized that cholesterol facilitates the interaction of Orai1 with STIM1 to 
mediate SOCE in PAEC. Experiments in this aim assessed the role of cholesterol in Orai1-
mediated SOCE using CH exposure in rats as a physiological stimulus to decrease PAEC 
cholesterol. Effects of Orai1 inhibition with AnCoA4 on SOCE were examined in isolated 
PAEC sheets from control and CH rats following cholesterol supplementation, 
epicholesterol substitution, or vehicle treatment. We further determined the role of 
cholesterol in Orai1-mediated SOCE by measuring SOCE in cholesterol-manipulated 
cultured pulmonary endothelial cells following either pharmacological inhibition of Orai1 
or Orai1 siRNA knockdown. In addition, the effect of cholesterol manipulation on STIM1-
Orai1 interaction was assessed by proximity ligation assay.  
20 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of the central hypothesis. We hypothesized that chronic 
hypoxia (CH) reduces membrane cholesterol levels in pulmonary artery endothelial cells 
and thus impairs agonist-induced Ca2+ entry and its components, store-operated Ca2+ entry 
and depolarization-induced Ca2+ entry. Changes of these Ca2+ entry pathways lead to 
reduced [Ca2+]i in pulmonary artery endothelial cells following CH. 
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Figure 2: Schematic representation of Aim 1. Cholesterol (Chol), endoplasmic reticulum 
(ER), inositol trisphosphate receptor (IP3R), store-operated Ca
2+ channel (SOC), T-type 
voltage gated calcium channel (T-type VGCC), receptor (R). 
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Figure 3: Schematic representation of Aim 2. Cholesterol (Chol), endoplasmic reticulum 
(ER), inositol trisphosphate receptor (IP3R), agonist (A), receptor (R). 
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Abstract 
Chronic hypoxia (CH)-induced pulmonary hypertension is associated with diminished 
production of endothelium-derived Ca2+-dependent vasodilators such as nitric oxide. 
Interestingly, ATP-induced endothelial Ca2+ entry as well as membrane cholesterol (Chol) 
are decreased in pulmonary arteries from CH rats (4 wk, PB = 380 Torr) compared to 
normoxic controls. Store-operated Ca2+ entry (SOCE) and depolarization-induced Ca2+ 
entry are major components of the response to ATP and are similarly decreased after CH.  
We hypothesized that membrane Chol facilitates both SOCE and depolarization-induced 
pulmonary endothelial Ca2+ entry, and that CH attenuates these responses by decreasing 
membrane Chol. To test these hypotheses, we administered Chol or epicholesterol 
(Epichol) to acutely isolated pulmonary arterial endothelial cells (PAEC) from control and 
CH rats to either supplement or replace native Chol, respectively. The efficacy of 
membrane Chol manipulation was confirmed by filipin staining. Epichol greatly reduced 
ATP-induced Ca2+ influx in PAEC from control rats. Whereas Epichol similarly blunted 
endothelial SOCE in PAEC from both groups, Chol supplementation restored diminished 
SOCE in PAEC from CH rats while having no effect in controls. Similar effects of Chol 
manipulation on PAEC Ca2+ influx were observed in response to a depolarizing stimulus 
of KCl. Furthermore, KCl-induced Ca2+ entry was inhibited by the T-type Ca2+ channel 
antagonist, mibefradil, but not the L-channel inhibitor, diltiazem. We conclude that PAEC 
membrane Chol is required for ATP -induced Ca2+ entry and its two components, SOCE 
and depolarization-induced Ca2+ entry, and that reduced Ca2+ entry after CH may be due 
to loss of this key regulator.  
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New & Noteworthy: This research is the first to examine the direct role of membrane 
cholesterol in regulating pulmonary endothelial agonist -induced Ca2+ entry and its 
components. The results provide a potential mechanism by which chronic hypoxia impairs 
pulmonary endothelial Ca2+ influx which may contribute to pulmonary hypertension. 
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Introduction 
Pulmonary vascular dysfunction resulting from chronic hypoxia (CH) leads to 
increased vascular resistance and pulmonary hypertension in patients with chronic lower 
respiratory diseases, sleep apnea, and in residents at high altitude. Vasoconstriction and 
vascular remodeling associated with dysregulation of endothelium-derived mediators are 
the major components of elevated vascular resistance in CH-induced pulmonary 
hypertension. Production of many endothelium-dependent vasoactive substances as well 
as regulation of membrane potential are largely a function of pulmonary endothelial 
intracellular calcium levels ([Ca2+]i). For example, [Ca
2+]i is a key regulatory factor in the 
activity of endothelial nitric oxide synthase (9, 17, 35, 42) phospholipase 2 (PLA2) (52, 
53), and the small and intermediate conductance Ca2+-activated potassium channels (SKCa 
and IKCa, respectively) that are responsible for endothelial cell hyperpolarization upon 
activation by agonists (22, 30). Diminished pulmonary endothelial [Ca2+]i may limit 
production of endothelium-derived vasodilators and anti-mitogenic substances including 
nitric oxide, prostacyclin, and endothelium-derived hyperpolarizing factors. Although 
endothelial dysfunction and an associated reduction in pulmonary artery endothelial [Ca2+]i 
and endothelium-derived nitric oxide (33, 38–40) may be contributing factors to the 
development of CH-induced pulmonary hypertension, the mechanisms by which 
endothelial [Ca2+]i is reduced following CH are incompletely understood. 
Our previous studies demonstrate that both basal [Ca2+]i and agonist-induced Ca
2+ 
influx are lower in pulmonary artery endothelial cells (PAEC) from CH rats compared to 
those of control animals (38, 39). CH similarly inhibits store-operated calcium entry 
(SOCE) and depolarization-induced Ca2+ influx through T-type voltage-gated Ca2+ 
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channels (VGCC), which are major components of agonist-induced Ca2+ entry in isolated 
PAEC (38, 40). Furthermore, agonist-induced Ca2+ influx along with membrane 
cholesterol levels are reduced in PAEC from rats exposed to CH. This impaired agonist-
induced Ca2+ influx in PAEC can be restored by both membrane cholesterol 
supplementation and by administration of a caveolin-1 (Cav-1) scaffolding domain peptide 
(39). The number and structure of caveolae, however, are not altered in PAECs from CH 
rats compared to controls (39). These data suggest that cholesterol per se may affect Ca2+ 
entry in these cells. However, questions remain as to whether cholesterol directly 
modulates endothelial agonist-induced Ca2+ entry and whether its major components, 
SOCE and depolarization-induced Ca2+ entry, are differentially affected. 
 The membrane cholesterol depleting agent, methyl-β-cyclodextrin (MβCD), has been 
used to investigate the importance of membrane cholesterol in cellular signaling pathways 
(58). However, by removing membrane cholesterol, MβCD can also disrupt caveolar 
structure (41). Consequently, this approach often raises the question of whether membrane 
cholesterol regulates signaling pathways by direct interaction with membrane proteins or 
rather by altering the properties of lipid microdomains. To address this problem, the 
enantiomer of cholesterol (epicholesterol), which has similar effects on membrane fluidity 
and lipid domain formation as those of cholesterol but lacks the regulatory influences of 
cholesterol on ion channel function, has been used as a tool to study cholesterol-ion channel 
interaction (1, 20, 29, 56). In the present study, we hypothesized that 1) membrane 
cholesterol facilitates SOCE and depolarization-induced Ca2+ entry in PAEC; and 2) 
reduced endothelial Ca2+ influx following CH is due to loss of membrane cholesterol. We 
tested this hypothesis by examining the effect of either membrane 
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cholesterol supplementation or cholesterol substitution with epicholesterol on endothelial 
Ca2+ entry in freshly isolated PAEC cells from normoxic and CH rats.  
 
Methods 
Animals and Chronic Hypoxic Exposure Protocol 
Male Sprague-Dawley rats (200-250 g) were used for all studies. Rats exposed to CH were 
placed in a hypobaric chamber with barometric pressure maintained at ≈380 Torr for 4 wk. 
Age-matched control rats were housed in similar cages under ambient barometric pressure 
(≈630 Torr). The hypobaric chamber was opened three times per week to provide fresh rat 
chow, water, and clean bedding. All animals were maintained on a 12:12-h light-dark cycle. 
All protocols used in this study were reviewed and approved by the Institutional Animal 
Care and Use Committee of the University of New Mexico Health Sciences Center. 
 
Preparation of cholesterol and epicholesterol solutions 
MβCD is a cyclic oligomer of glucose that when saturated with either cholesterol 
or epicholesterol, can effectively deliver these sterols to the plasma membrane (20). This 
approach has been used to enrich or substitute endogenous membrane cholesterol in 
neurons (50) and aortic endothelial cells (45). MβCD -cholesterol or -epicholesterol 
complexes were generated as described earlier (10). Briefly, the cyclodextrin-sterol 
solutions were prepared by the addition of sterols to MβCD (10 mM) in the molar ratio of 
1:5 and dissolution in HEPES buffer containing the following (in mM): 150 NaCl, 6 KCl, 
1 MgCl2, 1.8 CaCl2, 10 HEPES, and 10 glucose (pH 7.4). Each solution was vortexed and 
sonicated using a bath sonicator for 10-15 min. The saturated cyclodextrin-sterol solution 
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was then placed in a rotating incubator at 37 °C overnight. This stock solution was filtered 
through a 0.22 μm syringe filter, aliquoted, and stored at -80 °C. 
 
Isolation and preparation of pulmonary artery endothelial cells 
Following CH or normoxic exposure, rats were euthanized with pentobarbital 
sodium (200 mg/kg ip) and the heart and lungs were exposed by midline thoracotomy. The 
left lung was rapidly excised and placed in ice-cold HEPES buffer solution. Intrapulmonary 
arteries (3rd and 4th order, 200-400 μm inner diameter) were dissected from the superior 
region of the left lung, and the parenchymal lung tissue was carefully removed. Arteries 
were then cut longitudinally and treated with 0.2 mg/ml dithiothreitol and 2 U/ml papain 
in HEPES buffer for 45 min at 37 °C. Vessels were carefully removed from the digestion 
solution and placed in 1 ml of HEPES buffer containing 2 mg/ml bovine serum albumin. 
Pulmonary artery endothelial cell sheets were then released by gentle trituration with a 
small-bore fire-polished Pasteur pipette and stored at 4 °C. One to two drops of the solution 
containing freshly isolated rat PAEC were placed on a poly-L-lysine-coated glass cover 
slip and incubated at 37 °C in the presence vehicle, cholesterol, or epicholesterol. 
Cholesterol supplementation was performed in previously untreated endothelial sheets 
isolated from rats by incubation with cholesterol:MβCD (Chol:MβCD) solution for 30 min 
at 37 °C. Epicholesterol substitution was similarly achieved by incubating isolated PAEC 
with epicholesterol:MβCD (EpiChol:MβCD) solution for 30 min at 37 °C.   
 
Membrane cholesterol content  
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Rat PAEC were freshly isolated and prepared on poly-L-lysine-coated glass cover 
slips before treatment with vehicle, cholesterol, or epicholesterol. Briefly, cholesterol 
supplementation and epicholesterol substitution were performed by incubating PAEC with 
Chol:MβCD or EpiChol:MβCD solutions, respectively, for 30 min at 37 °C. Treated PAEC 
were then washed with PBS and fixed with 2% paraformaldehyde in PBS for 15 min at 
room temperature. Endothelial cell membrane cholesterol was detected by incubating cells 
with the fluorescent cholesterol marker filipin III (Sigma, 20 μg/ml) for 15 min at room 
temperature under light-protected conditions, and coverslips were mounted on the slides 
using mounting media (39). Slides were air-dried at 4 °C and stored at -20 °C until analysis. 
The samples were imaged by fluorescence confocal microscopy (Zeiss LSM 510 
AxioObserver; Göttingen, Germany) using 405-nm laser (excitation), a 420-nm long pass 
filter (emission), and a Plan-Neofluor X40/1.3 oil objective. Filipin staining was quantified 
using NIH Image J. A total of 25-100 cells per rat were analyzed. Fluorescence intensity 
was quantified by setting a threshold using blank control (filipin-untreated group). 
Fluorescence of each PAEC sheet was calculated and averaged to determine mean 
fluorescence for each animal.  
 
Endothelial caveolar number 
Cultured rat pulmonary microvascular endothelial cells (PMVEC, passage 6, 
cultured in MCDB-131 complete media, VEC Technologies) were treated with vehicle, 
MβCD, Chol:MβCD, or EpiChol:MβCD at 37 °C for 30 min. Cells were washed in HEPES 
buffer for 10 min and prepared for transmission electron microscopy (TEM) by fixation 
with 3% formaldehyde, 2% glutaraldehyde, and 1.5 mM CaCl2 in 0.1 M sodium cacodylate 
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buffer. Cells were post-fixed in reduced osmium tetroxide (1% OsO4 and 0.5% potassium 
ferrocyanide), dehydrated, embedded in epoxy resin, sectioned, and stained with uranyl 
acetate (saturated, aqueous). 
Caveolae between 60 and 100 nm in diameter were counted at the membrane of 
endothelial cells and divided by the length of cell membrane in μm using NIH Image J 
software. A total of 100 images encompassing 38 cells and 438 μm of membrane were 
analyzed by a person who was blinded to treatment. 
 
Endothelial fura-2 loading 
Following vehicle, cholesterol, or epicholesterol treatment, freshly isolated PAEC 
sheets were plated and loaded with fura-2 AM (3 μM and 0.05% pluronic acid) in HEPES 
buffer for 7 min at room temperature (≈23 °C) and washed for 15 min at 37 °C. Ratiometric 
changes in endothelial cell [Ca2+]i were determined by alternating a xenon arc lamp light 
source between 340- and 380- nm bandpass filters at 1 Hz (IonOptix Hyperswitch), and 
the interleaved fura-2 fluorescence emissions at 510 nm were detected with a 
photomultiplier tube.  
 
Agonist-induced Ca2+ influx and SOCE in freshly isolated endothelial cells 
Agonist-induced Ca2+ influx and SOCE were measured in PAEC sheets as 
described previously (39). After fura-2 loading and washing, fura-2-loaded endothelial 
sheets were superfused with Ca2+-free HEPES buffer for 5 min, then stimulated with ATP 
(20 μM) or cyclopiazonic acid (CPA, sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, 
10 μM) to deplete intracellular Ca2+ stores. Calcium entry was then induced by repletion 
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of extracellular Ca2+ (1.8 mM) in the continued presence of ATP or CPA. Ca2+ influx was 
quantified as the area under curve (AUC) for the 5 minutes following reintroduction of 
extracellular Ca2+.  
 
Measurement of PAEC Membrane Potential (Em) 
Endothelial Em was measured in en face small pulmonary arteries superfused with 
physiological salt solution (37 °C, equilibrated with 10% O2, 6% CO2) using glass 
microelectrodes (tip resistance 40–80 MΩ) filled with 3 M KCl. A Neuroprobe amplifier 
(A-M Systems) was used for recording Em. Analog output from the amplifier was low pass 
filtered at 1 kHz and recorded and analyzed using Axoscope software (Axon Instruments). 
Em was measured under baseline conditions and in response to 10 μM ATP. Criteria for 
acceptance of Em  recordings included: 1) an abrupt negative deflection of potential as the 
microelectrode was advanced into a cell; 2) a stable membrane potential for at least 1 min; 
and 3) an abrupt change in potential to 0 mV after the electrode was retracted from the cell.  
 
Depolarization-induced Ca2+ influx in freshly isolated endothelial cells 
The ratiometric changes in fura-2 fluorescence represent the sum of changes in 
intracellular [Ca2+]i, which includes Ca
2+ influx, Ca2+ uptake by organelles, and Ca2+ 
extrusion from the cell. To specifically assess Ca2+ entry, Mn2+ is used as a Ca2+ surrogate 
due to its unique property to traverse most Ca2+ -permeable channels (2), irreversibly bind 
to fura-2, and quench fura-2 fluorescence (wavelength at ~360 nm). Endothelial cell 
depolarization-induced Ca2+ influx was determined by Mn2+ quenching of fura-2 
fluorescence in freshly isolated PAEC sheets as describe previously (40). This preparation 
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was excited at the isosbestic wavelength (360 nm), and emission recorded at 510 nm. 
Similar to the previous protocol, fura-2-loaded endothelial sheets were superfused with 
Ca2+-free HEPES buffer for 5 min and administered KCL (60 mM) to elicit membrane 
depolarization. Calcium entry represented by the influx of the Ca2+ surrogate Mn2+ was 
then determined upon addition of extracellular Mn2+ (500 μM) in the continued presence 
of KCl. Depolarization-induced Ca2+ entry was quantified by the percentage of the Mn2+ 
quenched fluorescence at 120s after administration of Mn2+.  
 
Calculations and statistics 
All data are expressed as means ± SE. Values of n refer to the number of cells for 
experiment examining caveolar number or to the number of animals for other experiments. 
Percentage data were converted to normal distributions by arcsine transformation before 
parametric analysis. An unpaired t-test, one-way ANOVA, two-way ANOVA or Kruskal-
Wallis H test were used where appropriate for statistical comparisons. If differences were 
detected by ANOVA or the Kruskal-Wallis H test, individual groups were compared with 
the Student-Newman-Keuls or Dunn’s multiple comparison tests, respectively. A 
probability of < 0.05 was accepted as statistically significant for all comparisons. 
 
Results 
 
Effect of cholesterol manipulation on endothelial membrane cholesterol content 
Filipin is a polyene antibiotic that binds to membrane cholesterol via hydrophobic 
interaction (37), but cannot bind to epicholesterol (14). Consistent with our previously 
published data (39), filipin fluorescence was less in cells from CH rats compared with 
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normoxic rats (Fig. 1). Cholesterol supplementation restored diminished membrane 
cholesterol in cells from CH animals while having no effect in normoxic controls. 
Furthermore, epicholesterol treatment significantly reduced filipin fluorescence in freshly 
isolated PAEC from both control and CH rats. These data suggest that epicholesterol 
treatment is an effective approach to substitute endogenous membrane cholesterol for 
epicholesterol in this preparation. 
 
Effect of cholesterol manipulation on endothelial caveolar number  
Effects of cholesterol depletion, supplementation or substitution treatments on 
caveolar number and structure were examined in cultured rat PMVEC using transmission 
electron microscopy. MβCD, as a cholesterol carrier, can sequester membrane cholesterol 
and disrupt caveolar structure when used alone (21). Consistent with previous findings, 
MβCD decreased the incidence of caveolae (Fig. 2). In contrast, neither cholesterol 
supplementation nor epicholesterol substitution altered caveolar number compared to 
vehicle control. These results support an effect of epicholesterol treatment to substitute 
rather than deplete endogenous membrane cholesterol. 
 
Epicholesterol substitution attenuates endothelial ATP-induced Ca2+ entry 
ATP-induced Ca2+ entry and SOCE were assessed using ratiometric fura-2 
measurement as described previously (38, 39). Ca2+ entry was quantified as the AUC for 
the 5 minutes following reintroduction of extracellular Ca2+, in the continued presence of 
ATP or CPA (Fig. 3). ATP-induced Ca2+ entry was diminished in isolated PAEC from 
normoxic rats after EpiChol:MβCD treatment compared with vehicle controls, but was not 
57 
 
significantly altered by cholesterol supplementation (Chol:MβCD) (Fig.4). These data 
suggest that endothelial membrane cholesterol is necessary for agonist-induced Ca2+ entry. 
 
Cholesterol supplementation restores endothelial SOCE following CH 
To assess the importance of membrane cholesterol in SOCE, we examined effects 
of cholesterol supplementation and epicholesterol substitution on CPA-induced Ca2+ influx 
in isolated PAEC. SOCE was diminished in cells from CH rats compared with controls and 
was rescued by cholesterol repletion (Fig.5). Furthermore, epicholesterol substitution 
greatly inhibited CPA-induced Ca2+ entry in PAEC from both normoxic and CH rats when 
compared with their respective vehicle controls.   
 
ATP causes endothelial membrane depolarization 
We have previously demonstrated that CH inhibits depolarization-induced Ca2+ 
entry in PAEC (40). However, it is unclear if ATP elicits depolarization in these cells that 
could evoke this pathway. Consistent with this possibility, we found that ATP caused 
membrane depolarization in endothelium of freshly isolated pulmonary arteries from 
control rats (Fig. 6).  
 
Decreased membrane cholesterol leads to reduced endothelial depolarization-induced 
Ca2+ entry following CH 
Endothelial cell depolarization-induced Ca2+ influx was determined by Mn2+ 
quenching of fura-2 fluorescence in freshly isolated PAEC. Introduction of Mn2+ caused a 
steady decline in fura-2 fluorescence in the absence of KCl in PAEC from both control and 
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CH rats, indicative of basal Ca2+ entry (Fig. 7).  A depolarizing stimulus of KCl (60 mM) 
increased entry of the Ca2+ surrogate in isolated PAECs from control rats. However, this 
response to KCl was absent in in PAECs from CH rats.  
To confirm the involvement of T-type VGCCs in depolarization-induced Ca2+ 
influx (40), we repeated these experiments in the presence of the L-type Ca2+ channel 
inhibitor, diltiazem, or the T-type inhibitor, mibefradil. Whereas diltiazem did not affect 
responses to KCl in cells from either normoxic or CH rats, mibefradil abolished KCl-
induced Mn2+ quenching of fura-2 fluorescence in PAEC from normoxic controls, while 
having no effect in cells from CH rats (Fig. 8).  
Consistent with a requirement for membrane cholesterol in depolarization-induced 
Ca2+ entry, epicholesterol substitution prevented depolarization-induced Mn2+ entry in 
PAEC from normoxic rats, whereas cholesterol supplementation was without effect in 
these cells (Fig. 9). In addition, cholesterol repletion partially restored the KCl-induced 
Mn2+ influx in PAEC from CH rats, suggesting that reduced membrane cholesterol 
contributes to impaired depolarization-induced Ca2+ entry following CH. 
 
Discussion 
Our laboratory has previously shown that reduced membrane cholesterol following 
CH is associated with decreased ATP-induced Ca2+ entry in intrapulmonary artery 
endothelial cells. However, it is unclear if membrane cholesterol regulates endothelial Ca2+ 
entry through direct interaction with signaling molecules or through changes in physical 
properties of the plasma membrane. The goal of the present study was to determine the 
contribution of membrane cholesterol to agonist-induced Ca2+ entry and its major 
components, store-operated Ca2+ entry and Ca2+ entry through voltage-gated Ca2+ channels. 
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The major findings from this study are that substitution of endogenous membrane 
cholesterol with its epimer, epicholesterol, attenuates ATP-induced Ca2+ entry, SOCE and 
depolarization-induced Ca2+ entry in PAEC. In addition, decreased endothelial SOCE and 
depolarization-induced Ca2+ entry following CH are largely restored by cholesterol 
supplementation. However, neither cholesterol supplementation nor epicholesterol 
substitution alters endothelial caveolar number and structure. The results from this study 
suggest that membrane cholesterol directly regulates agonist-induced Ca2+ entry and its 
components and further demonstrate that impaired endothelial Ca2+ entry following CH is 
due to altered membrane cholesterol homeostasis. These findings provide an improved 
mechanistic understanding of factors that contribute to endothelial dysfunction and 
associated PH resulting from long-term hypoxic exposure.  
Many cells release ATP in response to mechanical signals including shear stress, 
extracellular fluid movement, and changes of cell volume (16, 51, 57). The activation of G 
protein-coupled purinergic receptors by released ATP may regulate myogenic tone and 
vascular remodeling (15, 25). In endothelial cells, shear stress-induced production of ATP 
serves as an autocrine factor and stimulates endothelial NO production (3). ATP as an 
agonist achieves its various roles through controlling intracellular Ca2+. Intracellular Ca2+ 
is a crucial second messenger affecting various cellular processes and is regulated by 
different pathways (6). Receptor-mediated Ca2+ influx is one of the major pathways to 
increase [Ca2+]i. The binding of an agonist to its receptor mediates activation of 
phospholipase C and production of inositol 1,4,5 trisphosphate (IP3). Cytosolic IP3 then 
binds to IP3 receptors on endoplasmic reticulum (ER), leading to depletion of the ER Ca
2+ 
store and subsequent  SOCE (44). Agonist binding may also elicit Ca2+ entry through 
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receptor-operated cation channels that are not activated by store emptying (47). 
Interestingly, agonists like ATP may further mediate depolarization-induced Ca2+ entry 
through VGCC secondary to activation of various nonselective cation channels, including 
transient receptor potential canonical (TRPC) channels and the ionotropic P2X receptor 
(11).  
Cholestrol is one of the key components of the plasma membrane and may affect 
cellular signaling. Direct interaction between sterols and ion channels has been suggested 
by the sensitivity of inwardly rectifying potassium (Kir) channels (45) and large 
conductance, Ca2+-activated potassium (BKCa) channels (8) to various sterol analogues. In 
addition, cholesterol binding regions exist in both Kir channels and BKCa channels (48, 49). 
However, the effect of membrane cholesterol on ion channel function may vary depending 
on the type of ion channel. For example, cholesterol decreases the open probability of many 
K+ channels, as well as voltage-gated Na+ and Ca2+ channels (13, 27, 52). In contrast, other 
ion channels such as epithelial Na+ channels and TRPC channels are inhibited by removal 
of membrane cholesterol (4, 5, 26). Regulation of SOCE by membrane cholesterol has been 
implicated in different cell types in previous studies (5, 19), in which membrane cholesterol 
depletion by MβCD impaired SOCE. However, the effect of membrane cholesterol in 
regulation of endothelial depolarization-induced Ca2+ entry is unknown.  
The importance of membrane cholesterol in agonist-induced Ca2+ entry has been 
suggested in cultured vascular smooth muscle cells, in which cholesterol enrichment 
augments agonist-induced Ca2+ influx (7). Our previous findings that cholesterol repletion 
enhances impaired ATP- induced Ca2+ entry in PAECs following CH (39) also suggests 
that membrane cholesterol may facilitate endothelial agonist-induced Ca2+ entry. ATP 
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induces both SOCE and T-type VGCC blocker -sensitive Ca2+  influx in PAECs (40).  In 
this study, we confirmed that ATP causes membrane depolarization in pulmonary artery 
endothelium, which may lead to T-type channel activation and Ca2+ influx. Considering 
that SOCE and depolarization-induced Ca2+ entry are major components of ATP- induced 
Ca2+ entry, and that both Ca2+ influx pathways are blunted following CH (38, 40), it is 
possible that membrane cholesterol also regulates these two components of the ATP-
induced Ca2+ response. 
Considering the wide range of effects of MβCD such as altering caveolar structure 
and disrupting other lipid microdomains (21), the direct contribution of membrane 
cholesterol to regulation of ion channels remains unclear. To investigate the direct role of 
membrane cholesterol in mediating endothelial Ca2+ influx, we used epicholesterol, the 
enantiomer of cholesterol, to substitute membrane cholesterol. Although epicholesterol has 
effects similar to cholesterol on physical properties of the cell membrane (56), few studies 
have examined the effect of EpiChol:MβCD on caveolae. Here we provide evidence that 
MβCD alone nearly abolished the incidence of caveolae, whereas neither Chol:MβCD nor 
EpiChol:MβCD affected caveolar number in cultured PMVEC. It has previously been 
shown that administration of an EpiChol:MβCD solution to bovine aortic endothelial cells 
effectively substitutes epicholesterol for endogenous membrane cholesterol (46). To verify 
this observation in our preparation, we assessed effects of epicholesterol substitution on 
membrane cholesterol content in freshly isolated PAEC using the fluorescent cholesterol 
marker, filipin. Epicholesterol does not interact with filipin due to a different orientation 
of the 3-hydroxyl group compared to cholesterol (14, 37). As expected, we found that 
epicholesterol treatment greatly decreased filipin fluorescence intensity in isolated PAEC 
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from both normoxic and CH rats, consistent with epicholesterol substitution of endogenous 
membrane cholesterol. In addition, cholesterol treatment restored membrane cholesterol 
content in PAEC from CH rats to the level of normoxic controls, consistent with our 
previous findings (39). These findings suggest that EpiChol:MβCD treatment substitutes 
endogenous membrane cholesterol for epicholesterol without disrupting caveolae.  
Consequently, the observed effects of epicholesterol treatment on Ca2+ influx are likely due 
to loss of ion channel regulation by cholesterol, rather than to changes in caveolar density.  
Using epicholesterol to substitute endogenous cholesterol, we demonstrated a direct 
role of membrane cholesterol to facilitate ATP-induced Ca2+ entry in PAEC. Our data are 
consistent with findings that depletion of membrane cholesterol impairs this Ca2+ response 
in PAEC (39). We also provide evidence that SOCE, as the major component of the ATP- 
induced Ca2+ response, is similarly regulated by membrane cholesterol. This observation 
implies that membrane cholesterol may either directly affect store-operated cation channels 
(SOCs) or interact with a signaling pathway that activates SOCs. The finding that reduced 
endothelial SOCE in pulmonary arteries following CH was acutely restored by membrane 
cholesterol supplementation suggests that CH limits SOCE by reducing membrane 
cholesterol rather than by decreasing ion channel expression. Although this study has not 
identified the specific cation channel(s) involved in pulmonary endothelial SOCE, 
candidates ion channels include TRPC1, TRPC4 and Orai1, each of which have been 
implicated in endothelial SOCE and demonstrate cholesterol-sensitivity (5, 12, 23, 32).  
Wu et al (54) first demonstrated that cultured rat PMVECs express mRNA of 
CaV3.1 and possess voltage-dependent current that are sensitive to T-type channel blockers. 
They also reported that T-type VGCCs contribute to both agonist-induced Ca2+ entry and 
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SOCE in PMVECs. Although T-type VGCCs are not found in cultured rat PAECs (54), 
their expression and function are described in freshly dispersed rat PAECs (40). Paffett et 
al showed that T-type VGCCs contribute to depolarization-induced Ca2+ entry and 
receptor-operated Ca2+ entry in response to ATP. Following exposure to CH, the mibefradil 
sensitive component of ATP-induced Ca2+ entry is greatly reduced. The effect of CH on 
this Ca2+ entry is not due to altered membrane K+ permeability, since the impaired 
endothelial depolarization-induced Ca2+ entry following CH persists even when membrane 
K+ permeability is equivalently clamped by K+ ionophore, valinomycin. These findings 
suggest that T-type VGCCs are important mediators of depolarization-induced Ca2+ entry 
and that impaired Ca2+ entry via these channels may contribute to reduced basal [Ca2+]i in 
PAECs after CH (40). Using the Mn2+ quenching technique to selectively assess Ca2+ entry, 
we confirmed that depolarization-induced Ca2+ entry was sensitive to T-type VGCC 
inhibition and Ca2+ entry was eliminated following CH. Additionally, depolarization-
induced Ca2+ entry following CH was partially restored by cholesterol supplementation. A 
similar effect of cholesterol on VGCCs has been reported in other cell types (55). Although 
studies on cholesterol regulation of VGCC are limited, our finding that epicholesterol 
substitution abolished depolarization-induced Ca2+ entry in control cells suggests that there 
may be a direct interaction between membrane cholesterol and T-type VGCCs that controls 
channel activity.  
Two potential mechanisms of decreased membrane cholesterol following CH 
include: 1) CH inhibits de novo cholesterol biosynthesis; and 2) CH induces membrane 
cholesterol oxidation. Mukodani et al. first reported that hypoxia induces lipid 
accumulation and impairs cholesterol synthesis in cultured rabbit skin fibroblasts (31). The 
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mechanism by which hypoxia affects cholesterol synthesis was later explored by Nguyen 
et al (36). They reported that hypoxia induces accumulation of cholesterol biosynthetic 
intermediates and activates HIF1-α-mediated induction of ER membrane proteins called 
insulin-induced gene. These two signaling pathways lead to rapid degradation of HMG-
CoA reductase and subsequently limit synthesis of cholesterol (36). Chronic hypoxia can 
also increase the production of reactive oxygen species (ROS) (18, 28), which may 
facilitate membrane cholesterol oxidation. Because filipin cannot be used to label oxidized 
cholesterol (43), it is possible that reduced filipin staining in PAECs of CH group is the 
result of membrane cholesterol oxidation by hypoxia-induced ROS. Cholesterol oxidation 
not only has potential to disrupt the interaction between cholesterol and ion channels and 
many regulatory proteins, but may also to inhibit de novo cholesterol synthesis (34). Future 
studies are required to evaluate the potential contributions of these mechanisms to reduced 
PAEC membrane cholesterol following CH. 
Regulation of intracellular Ca2+ levels is a complex process. It is interesting that 
CH impairs agonist-induced Ca2+ entry in PAEC via altered cholesterol regulation of 
potential ion channels. This decreased endothelial ATP-induced Ca2+ influx following CH 
is not associated with changes in ATP-induced Ca2+ mobilization (39), suggesting that 
attenuated Ca2+ entry is not due to altered Ca2+ release of Ca2+ loading of the ER after CH 
exposure. However, whether CH similarly affect other intracellular Ca2+ handling 
pathways like Ca2+ sequestration and efflux remains to be determined. It should also be 
noted that the impaired Ca2+ entry following CH is limited to endothelial cells of large 
pulmonary arteries and may not reflect those of smaller arteries and arterioles that likely 
contribute more to regulating vascular resistance in hypertensive pulmonary circulation. 
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Besides, both SOCE and receptor-operated Ca2+ entry in response to P2Y receptor agonist 
UTP are also reduced in pulmonary artery smooth muscle cells (PASMC) following CH 
(24). It rises another interesting question that whether CH impairs agonist-induced Ca2+ 
influx in PASMC through similarly mechanism involving membrane cholesterol observed 
in PACE. Future studies are needed to evaluate whether these effects of CH to alter calcium 
influx pathways are conserved across the pulmonary circulation and the impact of these 
responses to the development of CH-induced PH. 
In conclusion, the current study provides evidence that membrane cholesterol 
facilitates pulmonary endothelial Ca2+ entry likely through interaction with membrane ion 
channels. Our findings also demonstrate that impaired SOCE and depolarization-induced 
Ca2+ entry following CH are associated with reduced membrane cholesterol levels and are 
restored by cholesterol supplementation. This membrane cholesterol associated decrease 
of endothelial Ca2+ entry following CH may not only affect regulation of vascular tone, but 
also contribute to physiological changes, such as endothelial migration/proliferation and 
apoptosis. Our studies contribute to the understanding of the effect of CH on membrane 
cholesterol homeostasis and subsequent impact on endothelial [Ca2+]i in pulmonary 
arteries, which could shed light on developing potential therapeutic treatments for PH that 
target membrane cholesterol. Future studies will focus on identifying specific ion channels 
that interact with membrane cholesterol in pulmonary endothelial cells. 
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Figure 1. Epicholesterol reduces endogenous membrane cholesterol of freshly isolated 
PAEC sheets from both normoxic (Nor) and CH rats. A) Representative images of 
membrane cholesterol indicated by filipin fluorescence in PAEC isolated from each group. 
Cells were pretreated with vehicle, cholesterol (Chol), or epicholesterol (Epichol). Scale 
bars = 20 μm.  B) Mean filipin fluorescence (arbitrary units; A.U.) in PAEC sheets from 
each group. Two-way ANOVA followed by the Student-Newman-Keuls post-hoc test was 
used to compare between groups. Values are means ± SE; n = 3 animals/group. *P < 0.05 
vs. Nor vehicle; #P < 0.05 vs. CH vehicle. 
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Figure 2. Caveolae number is reduced by cholesterol depletion with MΒCD, but not by 
cholesterol or epicholesterol treatment in cultured PMVEC. A) Representative images of 
caveolae in cultured PMVEC from each treatment group. B) Mean number of caveolae per 
length of cell membrane (caveolae/μm). Data were compared by the Kruskal-Wallis H test 
and Dunn’s multiple comparison test. Values are means ± SE; n=7-11 cells (indicated in 
bars); *P < 0.05 versus all other treatments. A total of 100 images encompassing 38 cells 
and 438 μm of membrane were analyzed. 
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Figure 3. Experimental protocol for measuring ATP- and CPA- induced Ca2+ entry in 
isolated PAEC sheets. Depletion of intracellular Ca2+ store was induced by 20 μM ATP or 
10 μM CPA in a Ca2+-free HEPES buffer. Intracellular Ca2+ is expressed as the fura-2 
340/380 nm emission ratio. Ca2+ entry was assessed by calculating area under the curve 
(AUC) for the 5 min following reintroduction of extracellular Ca2+ (indicated by rectangle). 
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Figure 4. Epicholesterol substitution reduces ATP-induced Ca2+ entry in PAEC sheets 
from normoxic rats. Ca2+ influx was assessed by ratiometric analysis of fura-2 
fluorescence. One-way ANOVA followed by the Student-Newman-Keuls test was used to 
compare between groups. Values are means ± SE; n = 5 animals/group. *P < 0.05 vs. 
vehicle. 
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Figure 5. Decreased membrane cholesterol leads to reduced endothelial SOCE following 
CH. Ca2+ influx was assessed by ratiometric analysis of fura-2 fluorescence in PAEC 
sheets. Cholesterol supplementation restored CPA-induced Ca2+ entry following CH, 
whereas epicholesterol substitution significantly inhibited CPA-induced Ca2+ entry in 
PAEC sheets from both normoxic and CH rats. Groups were compared by two-way 
ANOVA followed by multiple comparisons testing using the Student-Newman-Keuls test. 
Values are means ± SE; n = 5-10 animals/group (indicated in bars).  *P <0.05 vs. Nor 
vehicle; #P <0.05 vs. CH Vehicle.  
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Figure 6. ATP induces membrane depolarization in pulmonary artery endothelium. 
Endothelial membrane potential was measured under baseline conditions and in response 
to 10 μM ATP in en face small pulmonary arteries from control rats. An unpaired t-test 
was used to compare between two groups. Values are means ± SE; n = 7, Baseline; n=6, 
ATP (3-6 Em recordings were conducted per artery and averaged for an n=1).  *P <0.05 vs. 
Baseline.  
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Figure 7. Exposure to CH abolishes endothelial depolarization-induced Ca2+ entry. A 
measure of endothelial Ca2+ entry was assessed by Mn2+ quenching of fura-2 fluorescence 
in PAEC sheets from control and CH rats treated with either vehicle (time control) or 60 
mM KCl (depolarizing stimulus). F, fluorescence intensity at 360 nm excitation; F0, 
fluorescence intensity at time zero. Two-way ANOVA and the Student-Newman-Keuls 
test were used to compare between groups at each time point. Values are means ± SE; n = 
5, Nor Vehicle; n = 5, CH Vehicle; n = 7, Nor KCl; n = 6, CH KCl. *P < 0.05 vs. Nor KCl 
over the range of 20 – 120 s. 
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Figure 8. CH attenuates depolarization-induced Ca2+ entry through T-type Ca2+ channels 
in PAEC. Data represent Mn2+-quenched fura-2 fluorescence (at 90 s time point) in 
response to KCl (60 mM) in PAEC sheets from control and CH rats. Diltiazem (50 μM) 
and mibefradil (10 μM) were used to selectively inhibit L-type and T-type Ca2+ channels, 
respectively. Data are expressed as ΔF/F0 (%) from time control. Two-way ANOVA and 
the Student-Newman-Keuls test were used to compare between groups. Values are means 
± SE; n = 4-7 animals/group (indicated in bars). *P < 0.05 vs. Nor vehicle; #P < 0.05 vs. 
Nor diltiazem. 
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Figure 9. Decreased membrane cholesterol leads to reduced endothelial depolarization-
induced Ca2+ entry following CH. Data represent Mn2+-quenched fura-2 fluorescence (at 
90 s time point) in response to KCl (60 mM) in PAEC sheets from control and CH rats. 
Cholesterol repletion partially restored depolarization-induced Ca2+ entry following CH. 
Epicholesterol greatly inhibited KCl-induced Ca2+ entry in PAEC from both normoxic and 
CH rats. Data are expressed as ΔF/F0 (%) from time control. Statistical comparisons were 
made using two-way ANOVA and the Student-Newman-Keuls post-hoc test. Values are 
means ± SE; n = 5-7 animals/group (indicated in bars). *P < 0.05 vs. Nor vehicle; #P < 
0.05 vs. Nor chol; ∆P < 0.05 vs. CH vehicle. 
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Abstract 
Endothelial dysfunction in chronic hypoxia (CH)-induced pulmonary hypertension 
is characterized by reduced store-operated Ca2+ entry (SOCE) and diminished Ca2+-
dependent production of endothelium-derived vasodilators.  We recently reported that 
SOCE in pulmonary arterial endothelial cells (PAEC) is tightly regulated by membrane 
cholesterol, and that decreased membrane cholesterol is responsible for impaired SOCE 
following CH.  However, the ion channels involved in cholesterol-sensitive SOCE are 
unknown.  We hypothesized that cholesterol facilitates SOCE in PAEC through the 
interaction of Orai1 and stromal interaction molecule 1 (STIM1).  The role of cholesterol 
in Orai1-mediated SOCE was initially assessed using CH exposure in rats (4 wk, 380 
mmHg) as a physiological stimulus to decrease PAEC cholesterol.  Effects of Orai1 
inhibition with AnCoA4 on SOCE were examined in isolated PAEC sheets from control 
and CH rats following cholesterol supplementation, substitution of endogenous cholesterol 
with epicholesterol (Epichol), or vehicle treatment. Whereas cholesterol restored 
endothelial SOCE in CH rats, both Epichol and AnCoA4 attenuated SOCE only in 
normoxic controls. The Orai1 inhibitor had no further effect in cells pretreated with 
Epichol.  Using cultured pulmonary endothelial cells to allow better mechanistic analysis 
of the molecular components of cholesterol-regulated SOCE, we found that Epichol, 
AnCoA4 and Orai1 siRNA each inhibited SOCE compared to their respective controls.  
Epichol had no additional effect following knockdown of Orai1.  Furthermore, Epichol 
substitution significantly reduced STIM1-Orai1 interaction assessed by proximity ligation 
assay.  We conclude that membrane cholesterol is required for the STIM1-Orai1 interaction 
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necessary to elicit endothelial SOCE. Furthermore, reduced PAEC membrane cholesterol 
following CH limits Orai1-mediated SOCE.  
Key Words: pulmonary hypertension, STIM1, store-operated Ca2+ entry. 
New & Noteworthy: This research demonstrates a novel contribution of cholesterol to 
regulate the interaction of Orai1 and STIM1 required for pulmonary endothelial agonist-
induced Ca2+ entry. The results provide a mechanistic basis for impaired pulmonary 
endothelial Ca2+ influx following CH that may contribute to pulmonary hypertension. 
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Introduction 
Endothelial dysfunction in pulmonary hypertension is characterized by imbalanced 
production of endothelium-derived vasocontrictors and vasodilators leading to 
vasoconstriction, vascular remodeling, and subsequent elevation of pulmonary vascular 
resistance (8, 21, 75). The production of many endothelium-derived vasodilators and anti-
mitogenic compounds, including nitric oxide (NO), prostacyclin, and endothelium-derived 
hyperpolarizing factors is closely regulated by endothelial intracellular calcium levels 
([Ca2+]i) (9, 17, 25, 45, 47). Diminished pulmonary endothelial [Ca
2+]i and limited 
production of endothelium-derived NO are associated with the development of chronic 
hypoxia (CH)-induced pulmonary hypertension (51, 56). However, the mechanisms of 
reduced pulmonary endothelial [Ca2+]i following CH exposure are not well-investigated. 
Endothelial store-operated Ca2+ entry (SOCE) is required for endothelium-
dependent vasorelaxation in systemic arteries (28), in part through production of NO (3). 
SOCE is initiated when a stimulated G protein-coupled receptor activates phospholipase C 
(PLC), which produces inositol 1,4,5 trisphosphate (IP3) by hydrolyzing 
phosphatidylinositol bisphosphate (PIP2). IP3, as a second messenger, activates IP3 
receptors on the endoplasmic reticulum (ER) membrane, leading to rapid ER Ca2+ release. 
ER Ca2+ store depletion then activates store-operated cation channels (SOC), which leads 
to sustained Ca2+ influx (64). Stromal interaction molecule 1 (STIM1) has been identified 
as an ER Ca2+ sensor and was suggested as the essential link between Ca2+ store depletion 
and SOC activation (72). As ER Ca2+ levels fall, STIM1 molecules oligomerize on the ER 
membrane and interact with SOC on the cell membrane, which include Orai channels (15). 
Orai1, one of three isoforms of Orai found in mammalian cells, mediates SOCE when 
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activated by STIM1 (86). The STIM1-Orai1 interaction occurs in cholesterol-rich caveolae 
on the cell membrane. Interestingly, intact caveolae are required for activation of Orai1-
mediated SOCE in platelets (14). Depletion of membrane cholesterol not only inhibits 
SOCE, but also interupts STIM1 clustering near the cell membrane (59). However, whether 
membrane cholesterol directly faciliates STIM1-Orai1 interaction and SOCE activation or 
indirectly modulates this Ca2+ entry pathway by contributing to lipid raft integrity is not 
clear. 
We have previously reported that decreased endothelial SOCE following CH is 
associated with diminished membrane cholesterol  and this reduced SOCE is restored by 
cholesterol supplementation (56, 57, 84). Furthermore, to study the functional role of 
membrane cholesterol in regulating SOCE, epicholesterol (Epichol) was used to replace 
native cholesterol.  As the enantiomer of cholesterol, Epichol has similar effects on 
membrane fluidity and lipid domain formation as those of cholesterol but lacks the 
regulatory influences of cholesterol on ion channel function (22, 65, 83). Substitution of 
endogenous cholesterol with Epichol mimics the effect of CH in reducing endothelial 
SOCE while having no effect on caveolar number (84). However, the mechanisms by 
which reduced endothelial membrane cholesterol limits SOCE following CH are not clear. 
In the present study, we hypothesized that cholesterol facilitates the interaction of Orai1 
with STIM1 to mediate SOCE in PAEC. We tested this hypothesis by examining the effects 
of either cholesterol or Epichol treatment combined with Orai1 inhibition on SOCE in both 
freshly isolated pulmonary arterial endothelial cells (PAEC) from normoxic and CH rats 
and in cultured pulmonary microvascular endothelial cells (PMVEC).  
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Methods 
Animals and Chronic Hypoxic Exposure Protocol 
Male Sprague-Dawley rats (200-250 g) were used for in vivo and ex vivo studies. 
Rats exposed to CH were placed in a hypobaric chamber with barometric pressure 
maintained at ≈ 380 mmHg (inspired PO2 ≈ 70 mmHg) for 4 wk (84). Age-matched control 
rats were housed in similar cages under ambient barometric pressure (≈ 630 mmHg in 
Albuquerque, NM). The hypobaric chamber was opened three times per week to provide 
fresh rat chow, water, and clean bedding. All animals were maintained on a 12:12-h light-
dark cycle. All protocols used in this study were reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of New Mexico Health Sciences Center. 
Isolation and preparation of pulmonary artery endothelial cells 
Following CH or normoxic exposure, rats were euthanized with pentobarbital 
sodium (200 mg/kg ip) and the heart and lungs were exposed by midline thoracotomy. The 
left lung was rapidly excised and placed in ice-cold HEPES buffer solution. Intrapulmonary 
arteries (3rd and 4th order, 200-400 μm inner diameter) were dissected from the superior 
region of the left lung, and the parenchymal lung tissue was carefully removed. Arteries 
were then cut longitudinally and treated with 0.2 mg/ml dithiothreitol and 2 U/ml papain 
in HEPES buffer for 45 min at 37 °C. Vessels were carefully removed from the digestion 
solution and placed in 1 ml of HEPES buffer containing 2 mg/ml bovine serum albumin. 
PAEC sheets were then released by gentle trituration with a small-bore fire-polished 
Pasteur pipette and stored at 4 °C. One to two drops of the solution containing freshly 
isolated rat PAEC were placed on a poly-L-lysine-coated glass cover slip and incubated at 
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37 °C for 30 min prior to experimentation (84). PAEC sheets collected using this approach 
are identified by their distinct morphology (57, 84) and uptake of Dil-Ac-LDL (56). 
Cell culture 
To complement experiments using freshly isolated PAEC sheets, cultured 
pulmonary microvascular endothelial cells (PMVEC; VEC Technologies) were also used 
in this study. Cultured cells permit the use of genetic manipulation with siRNA and 
determination of protein-protein interactions (Orai1-STIM1) using proximity ligation 
assay for better mechanistic analysis of the molecular components of cholesterol-regulated 
SOCE. PMVEC were maintained in a humidified incubator at 37 °C with 5% CO2 in 
MCDB-131 complete media (VEC Technologies).  Cultures were split every 4-6 days and 
cells studied between passages 5 and 10.  Depending on the experimental protocol, cells 
were seeded onto round poly-L-lysine-coated glass coverslips in 6-well plates, 6-well 
plates coated with attachment factors, or 18-well slides coated with attachment factors.  
Preparation of cholesterol and epicholesterol solutions 
Solutions were prepared by saturating methyl-β-cyclodextrin (MβCD) with either 
cholesterol or Epichol, as decribed previously (11). Briefly, the cyclodextrin-sterol 
solutions were prepared by the addition of sterols to MβCD (10 mM) in a molar ratio of 
1:5 and dissolution in HEPES buffer containing the following (in mM): 150 NaCl, 6 KCl, 
1 MgCl2, 1.8 CaCl2, 10 HEPES, and 10 glucose (pH 7.4). Each solution was vortexed and 
sonicated using a bath sonicator for 10-15 min. The saturated cyclodextrin-sterol solution 
was then placed in a rotating incubator at 37 °C overnight. This stock solution was filtered 
through a 0.22 μm syringe filter, aliquoted, and stored at -80 °C. 
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Endothelial cell membrane cholesterol manipulation 
Cholesterol supplementation was performed in untreated PAEC or PMVEC by 
incubation with the cholesterol/MβCD solution for 30 min at 37 °C (84). Epichol 
substitution was similarly achieved by incubating isolated PAEC or cultured PMVEC with 
the Epichol/MβCD solution under the same conditions. Preliminary studies revealed that, 
in contrast to effects of membrane cholesterol manipulation in freshly dispersed PAEC 
from normoxic rats (84), cholesterol supplementation increased SOCE in cultured PMVEC 
and conferred sensitivity to Epichol substitution (data not shown), suggesting that 
membrane cholesterol content is reduced under cell culture conditions compared to the 
native state. Therefore, cultured PMVEC were pretreated with cholesterol/MβCD solution 
prior to experimentation to mimic responses of native PAEC cells.  
Ca2+ influx in freshly isolated and cultured pulmonary endothelial cells 
Following vehicle, cholesterol, or Epichol treatment, freshly isolated PAEC sheets 
or cultured PMVEC (passages 5-10) were loaded with fura-2 AM (3 μM and 0.05% 
pluronic acid) in HEPES buffer for 7 min at room temperature (≈23 °C) and washed for 15 
min at 37 °C. SOCE, depolarization-induced Ca2+ influx, and receptor-operated Ca2+ influx 
were measured by Mn2+-quenching of fura-2 fluorescence in PAEC sheets or PMVEC as 
previously described (84). Mn2+ enters the cell as a Ca2+ surrogate and reduces fura-2 
fluorescence upon binding to the fluorophore. The preparation was excited at the isosbestic 
wavelength (360 nm) at 1 Hz (IonOptix Hyperswitch), and emission recorded at 510 nm 
with a photomultiplier tube. At this excitation wavelength, fura-2 fluorescence intensity is 
not influenced by changes in [Ca2+]i, thus providing a measure of Ca
2+ influx as reflected 
by Mn2+ uptake independent of ER Ca2+ release, sequestration or efflux across the cell 
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membrane (31). Fura-2-loaded endothelial cells were superfused with Ca2+-free HEPES 
buffer in the presence of vehicle or AnCoA4 (20 μM, Orai1 inhibitor (67)) for 5 min and 
administered the sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, cyclopiazonic acid 
(CPA, 10 μM) to deplete intracellular Ca2+ stores and activate store-operated channels. To 
confirm the specificity of AnCoA4 as an inhibitor of SOCE, KCl (60 mM) or 1-oleoyl-2-
acetyl-sn-glycerol (OAG, diacylglycerol analog, 50 μM) were applied in separate studies 
to examine the effect of AnCoA4 on depolarization-induced and receptor-operated Ca2+ 
influx (58), respectively. Ca2+ entry represented by influx of the Ca2+ surrogate Mn2+ was 
then determined upon addition of extracellular Mn2+ (500 μM) in the continued presence 
of AnCoA4 or vehicle. SOCE was quantified by the percentage of the Mn2+ quenched 
fluorescence at 120 s after administration of Mn2+. 
Membrane cholesterol content  
We have previously used the fluorescent cholesterol marker, filipin, to determine 
the efficacy of cholesterol manipulation protocols in freshly dispersed PAEC (84). To 
confirm similar effectiveness of cholesterol manipulation in PMVEC, cultures (passage 6) 
were treated with vehicle, MβCD, cholesterol:MβCD, or Epichol:MβCD at 37 °C for 30 
min, then washed with PBS and fixed with 2% paraformaldehyde in PBS for 15 min at 
room temperature. Endothelial cell membrane cholesterol was detected by incubating cells 
with filipin III (Sigma, 20 μg/ml) for 15 min at room temperature under light-protected 
conditions, and coverslips were mounted on the slides using mounting media (57). Slides 
were air-dried at 4 °C and stored at -20 °C until analysis. The samples were imaged by 
fluorescence confocal microscopy (Zeiss LSM 510 AxioObserver; Göttingen, Germany) 
using 405-nm laser (excitation), a 420-nm long pass filter (emission), and a Plan-Neofluor 
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X40/1.3 oil objective. Filipin fluorescence intensity was quantified using NIH Image J, and 
calculated as that above threshold assessed using a blank control (filipin-untreated group). 
Fluorescence of each PMVEC was calculated and averaged to determine mean 
fluorescence for each treatment group. Cellular cholesterol content was also examined 
using an Amplex Red cholesterol assay kit (Molecular Probes) following manufacturer 
instructions. 
Orai1 siRNA knockdown 
A cocktail of three different Orai1 siRNAs was used (Thermofisher, RSS357633-
357635). Transfection in PMVEC (passages 6-10) was achieved using lipofectamine 
(Invitrogen) according to the manufacturer’s instructions. A scrambled sequence 
(Dharmacon) was used as a non-targeting (NT) control. Cells seeded onto either round 
glass coverslips (for Ca2+ imaging) or 6-well plates (for Western blotting) were transfected 
with 9 μg of siRNA in each well and were assayed 72 hr after transfection. There were no 
apparent effects of either siRNA or NT treatments on cell morphology. 
Western blotting for Orai1 
PMVEC were homogenized in a buffered solution (255 mM sucrose, 10 mM Tris 
HCl, 2 mM EDTA, 12 μM leupeptin, 1 μM pepstatin A, and 0.3 μM aprotinin) and 
centrifuged at 500 x g for 5 min at 4 °C. Cell lysate protein content was quantified using a 
NanoDrop (NanoDrop 2000, Thermofisher) and 50 g of protein were separated by SDS-
PAGE (12% Tris/glycine) and transferred onto polyvinylidene fluoride membranes. After 
blocking with 5% nonfat milk dissolved in Tri-buffered saline with 0.1% Tween 20 (TBS-
T) for 1 hr at room temperature, the membrane was probed with primary antibody (1:400, 
rabbit anti-Orai1, ACC-062, Alomone Labs) in TBS-T containing 5% non-fat milk 
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overnight at 4 °C. After washing, the membrane was incubated with secondary antibody 
(IgG-horseradish peroxidase-conjugated goat anti-rabbit, 1:3000, Bio-Rad) in TBS-T 
containing 0.5% non-fat milk for 1 h at room temperature. Anti-β-actin (1:5000) was used 
for loading control experiments in which the same membrane probing for Orai1 above was 
washed and reprobed for β-actin. Detection was performed with the enhanced 
chemiluminescence reagent (ECL Western blotting detection reagents, Pierce) and 
chemiluminescence-sensitive film (GeneMate). All bands of targeted size were quantified 
by densitometry using the ImageJ software. 
Duolink proximity ligation assay 
STIM1-Orai1 interaction is required for the activation of Orai1 channels and 
SOCE. To determine whether cell membrane cholesterol regulates this pivotal step in 
SOCE, the interaction of STIM1 and Orai1 was assessed in PMVEC using the Duolink in 
situ proximity ligation assay (PLA) according to manufacturer’s instructions (Sigma-
Aldrich). Briefly, PMVEC were plated on 18-well slides (Ibidi) and grown to 80-90% 
confluency. PMVEC pretreated with cholesterol or Epichol were then treated with either 
vehicle or CPA (10 μM; 5 min) before fixing with 2% paraformaldehyde. PMVEC were 
incubated with Duolink blocking buffer for 30 min at 37°C then incubated overnight with 
rabbit anti-STIM1 (1:250; ab106531, Abcam) and goat anti-Orai1 (1:100; sc-74778, Santa 
Cruz Biotechnology). Cells were then incubated with anti-rabbit PLUS and anti-goat 
MINUS PLA probes (1:5) for 1 hr at 37°C. Negative controls were completed by 1) 
omission of primary antibody, and 2) incubation with each primary antibody individually. 
Samples were amplified with Duolink In Situ Detection Reagent Orange 
(excitation/emission: 554/579 nm; Sigma-Aldrich) for 100 min at 37°C. SYTOX Green 
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(1:5,000; Invitrogen) was used as a nuclear stain. Samples were mounted with Duolink 
mounting media and Z-stack images of the PLA interaction were acquired using a confocal 
microscope (TCS SP5; Leica). The number of puncta per cell were determined using Image 
J (NIH). 
Calculations and statistics 
All data are expressed as means ± SE. Values of n refer to the number of animals 
for experiments using freshly isolated PAEC or to the number of groups as indicated in 
figure legends for other experiments. Percentage data were converted to normal 
distributions by arcsine transformation before parametric analysis. An unpaired t-test, one-
way ANOVA, two-way ANOVA or Kruskal-Wallis H test were used where appropriate 
for statistical comparisons. If differences were detected by ANOVA or the Kruskal-Wallis 
H test, individual groups were compared with the Student-Newman-Keuls or Dunn’s 
multiple comparison tests, respectively. A probability of < 0.05 was accepted as 
statistically significant for all comparisons. 
 
Results 
Impaired pulmonary endothelial SOCE following CH is restored by cholesterol 
supplementation 
The importance of membrane cholesterol in diminished SOCE following CH was 
confirmed by examining effects of cholesterol supplementation and Epichol substitution 
on CPA-induced Ca2+ influx in freshly isolated PAEC from control and CH rats using the 
Mn2+ quenching technique. Although cholesterol treatment did not affect endothelial 
SOCE in normoxic rats, Epichol substitution greatly inhibited this Ca2+ entry pathway (Fig. 
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1A). In contrast, cholesterol repletion increased SOCE in PAEC of CH rats (Fig. 1B). 
Treatment with Epichol did not further attenuate SOCE in PAEC from CH rats compared 
to vehicle treated cells (Fig. 1B). These data are summarized in Figure 1C. Exposure to CH 
significantly blunted SOCE compared to normoxic controls, which was restored by 
cholesterol supplementation (Fig. 1C).  In cells from normoxic animals, treatment with 
Epichol reduced SOCE, mimicking the effects of CH exposure. 
Orai1 mediates pulmonary endothelial SOCE 
We initially assessed the contribution of Orai1 to pulmonary endothelial SOCE 
using the Orai1 inhibitor, AnCoA4 (REF). AnCoA4 was originally identified as an 
inhibitor of Orai1 using minimal functional domains of Orai1 and STIM1 to screen small-
molecule microarrays. This compound was found to directly bind to the C-terminus of 
Orai1 and interfere not only with channel gating but also with the interaction of Stim1 and 
Orai1.  The specificity of AnCoA4 to inhibit SOCE was confirmed by comparing its 
effectiveness to attenuate SOCE vs. other forms of Ca2+ entry not linked to Orai1, including 
depolarization-induced Ca2+ entry mediated by T-type voltage-gated Ca2+ channels (REF) 
and receptor-operated Ca2+ entry in response to the diacylglycerol analog, OAG (REF). In 
PAEC from normoxic rats. AnCoA4 significantly attenuated CPA-induced SOCE without 
affecting Ca2+ entry to a depolarizing stimulus of KCl (Fig. 2A). AnCoA4 similarly 
reduced SOCE without affecting receptor-operated Ca2+ influx elicited by OAG (Fig. 2B) 
in cultured PMVEC where this pathway of influx is more demonstrable.  Together, these 
data establish the specificity of AnCoA4 as a SOCE-specific inhibitor.  
CH impairs Orai1-mediated pulmonary endothelial SOCE: role of membrane cholesterol 
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The effect of CH on Orai1-mediated endothelial SOCE was examined using 
AnCoA4 in freshly isolated PAEC from normoxic and CH rats. Orai1 inhibition 
significantly reduced endothelial SOCE in PAEC from normoxic rats (Fig. 3A, B), while 
having no effect in cells from CH animals (Fig. 3A, C). However, AnCoA4-sensitive 
SOCE was restored by cholesterol supplementation in PAEC from CH rats (Fig. 3C), 
mirroring the efficacy of Orai1 inhibition in cholesterol-treated cells from normoxic rats 
(Fig. 3B). In contrast, Orai1 inhibition was without effect on Ca2+ influx following Epichol 
substitution in PAEC from either normoxic (Fig. 3B) or CH rats (Fig. 3C). 
Effect of cholesterol manipulation on membrane cholesterol content in cultured PMVEC. 
To further explore the mechanism by which membrane cholesterol regulates Orai1-
mediated endothelial SOCE, we focused on cultured PMVEC where genetic approaches 
and assessment of protein-protein association are technically more feasible. We first 
examined the effect of cholesterol manipulation on endothelial cell membrane cholesterol 
levels. Consistent with previous observations in freshly isolated PAEC (84), both MβCD 
and Epichol treatment significantly reduced filipin fluorescence (Fig.4A, B). Interestingly, 
cholesterol supplementation increased filipin fluorescence in cultured PMVEC (Fig.4A, 
B), which is different from our previous observation in freshly isolated PAEC where 
cholesterol treatment did not further augment filipin fluorescence (57). We also examined 
endothelial cholesterol content using an Amplex Red cholesterol assay. Consistently, 
cholesterol treatment augmented endothelial cholesterol content while MβCD and Epichol 
treatment reduced native cholesterol content (Fig.4C). Since these results suggest that 
cultured cells are relatively cholesterol deplete, PMVEC used in the following studies were 
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first supplemented with cholesterol prior to subsequent manipulation to better mimic native 
cells. 
Epicholesterol substitution reduces SOCE in PMVEC 
SOCE was assessed in cultured PMVEC after cholesterol manipulation. Similar to 
that observed in native cells, Epichol substitution significantly reduced endothelial SOCE 
compared to the cholesterol-treated group (Fig. 5).  
Orai1 siRNA knockdown inhibits membrane cholesterol-mediated SOCE in PMVEC 
Orai1 siRNA was employed as a genetic approach to complement pharmacological 
inhibition studies using AnCoA4 and further control for potential off-target effects of the 
inhibitor.  The efficacy of Orai1 siRNA knockdown was confirmed by western blotting. 
Orai1 siRNA had a moderate but significant effect to reduce Orai1 protein expression 
compared with the NT control siRNA (Fig. 6A, B). Consistent with pharmacologic Orai1 
inhibition in both native and cultured cells (Fig. 2A, B), Orai1 siRNA knockdown 
attenuated SOCE in PMVEC (Fig. 6C). Furthermore, Epichol substitution greatly reduced 
endothelial SOCE of the NT group without affecting that of Orai1 siRNA-treated cells 
(Fig. 6C). Together these findings confirm the involvement of Orai1 in cholesterol-
sensitive SOCE.    
Epicholesterol substitution reduces STIM1-Orai1 interaction in PMVEC 
The role of membrane cholesterol in regulating STIM1-Orai1 interaction was 
examined in PMVEC. CPA-induced ER store depletion increased STIM1-Orai1 co-
localization (i.e., increased the number of red puncta) (Fig. 7A, B). Epichol treatment, 
however, nearly abolished STIM1-Orai1 co-localization when compared to the cholesterol-
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treated group (Fig.7A, B), supporting a role for membrane cholesterol to facilitate the 
interaction of STIM1 and Orai1 in PMVEC.  
 
Discussion 
Our laboratory has previously shown that reduced membrane cholesterol following 
CH is associated with impaired SOCE in intrapulmonary artery endothelial cells, and that 
endothelial membrane cholesterol facilitates SOCE through direct interaction with 
signaling molecules. However, the mechanism by which membrane cholesterol-regulated 
endothelial Ca2+ entry via SOC has not previously been addressed. The goal of the present 
study was to determine the contribution of membrane cholesterol to Orai1-mediated SOCE 
in pulmonary endothelial cells. The major findings from this study are that 1) restoration 
of SOCE by cholesterol supplementation in PAEC from CH rats is sensitive to Orai1 
inhibition; 2) both substitution of endogenous membrane cholesterol with its epimer, 
Epichol, and inhibition of Orai1 by AnCoA4 attenuate SOCE without additive effects in 
isolated PAEC and cultured PMVEC; 3) Epichol treatment does not further reduce SOCE 
in PMVEC following Orai1 siRNA knockdown; and 4) membrane cholesterol is required 
for the interaction of STIM1 and  Orai1 in response to ER Ca2+ store depletion in PMVEC. 
The results from this study suggest that membrane cholesterol directly regulates Orai1-
mediated endothelial SOCE by facilitating the interaction of STIM1 and Orai1, and further 
demonstrate that impaired pulmonary endothelial Ca2+ entry following CH is due to altered 
membrane cholesterol homeostasis that limits Orai1 activity. 
One of the hallmarks of CH-induced pulmonary hypertension is pulmonary arterial 
endothelial dysfunction. Pulmonary arterial smooth muscle cell contraction and 
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proliferation is regulated by vasoactive factors secreted from the endothelium. The 
increased production of vasoconstrictors/proliferative factors and decreased synthesis of 
vasodilatory/anti-mitogenic factors contribute to enhanced vascular tone and remodeling 
in CH-induced pulmonary hypertension (71). Production of many endothelium-dependent 
vasodilators as well as regulation of membrane potential are largely a function of 
pulmonary endothelial intracellular calcium levels ([Ca2+]i). The activity of endothelial 
nitric oxide synthase (9, 17, 53, 62), phospholipase 2 (PLA2) (43, 69), and the small and 
intermediate conductance Ca2+-activated potassium channels (SKCa and IKCa, respectively) 
that are responsible for endothelial cell hyperpolarization upon activation by agonists (25, 
45) are regulated by [Ca2+]i. Thus, diminished pulmonary endothelial [Ca
2+]i may limit 
production of these endothelium-derived vasoactive factors. In CH-induced pulmonary 
hypertension, for example, posttranslational regulation of eNOS activity is impaired due to 
reduced agonist-induced Ca2+ influx (51). Our previous work also shows that both basal 
[Ca2+]i and agonist-induced Ca
2+ influx are lower in PAEC from CH rats compared to those 
of control animals (56, 57). CH similarly inhibits endothelial SOCE, receptor-operated 
Ca2+ entry, and T-type VGCC-mediated depolarization-induced Ca2+ influx, which are 
major components of agonist-induced Ca2+ entry in isolated PAEC (56, 58). These findings 
suggest that store-operated channels and T-type VGCCs are important in determining 
endothelial Ca2+ influx, and impaired Ca2+ entry through these channels may contribute to 
reduced basal [Ca2+]i in PAEC after CH. Previous studies from our laboratory suggest that 
CH inhibits endothelial Ca2+ influx through alterations in membrane lipid domains, which 
represent key regulatory sites of ion channel function in PAEC (57, 84).  
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Cholesterol is a polycyclic amphipathic molecule with a polar section consisting of 
a single β-hydroxyl group that can interact with membrane lipids or proteins through 
formation of hydrogen bonds (61). Cholesterol-enriched caveolar microdomains are signal 
transduction platforms where many ion channels and their regulatory factors reside (71). 
Membrane cholesterol can inhibit some ion channels by decreasing open probability, 
unitary conductance, and the number of active channels (38). In contrast, ion channels such 
as the nicotinic acetylcholine receptor, GABA receptors, epithelial Na+ channels and TRPC 
channels are inhibited by removal of membrane cholesterol (4–6, 32, 73), indicating an 
important role for cholesterol in normal channel function.  Consistent with this regulatory 
function, our previous studies show that membrane cholesterol facilitates major Ca2+ entry 
pathways in PAEC, including agonist-induced Ca2+ entry, SOCE, and depolarization-
induced Ca2+ entry, and that CH impairs endothelial Ca2+ influx by reducing membrane 
cholesterol levels (84). However, the mechanisms by which cholesterol regulates 
endothelial Ca2+ influx are not well-investigated.   
The current study focused on exploring the ion channel involved in membrane 
cholesterol-dependent endothelial SOCE, a major component of agonist-induced Ca2+ 
entry, in the pulmonary circulation. Orai1 and transient receptor potential canonical 
channels (TPRC) have been reported as putative SOC (18, 40, 60, 82, 87). Depletion of ER 
Ca2+ stores causes STIM1 oligomerization (15, 39), which recruits Orai1 into 
microdomains and ensures the physical interaction between STIM1 and Orai1, leading to 
Orai1 activation and Ca2+ influx (86). TRPC1 and TRPC4 channels also localize to 
caveolar microdomains and regulate endothelial Ca2+ entry in murine PMVEC (50). 
However, TRPC1-mediated SOCE is less Ca2+ selective compared to Orai1-mediated 
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SOCE (35) and requires functional Orai1 (34). Orai1 also interacts with TPRC4 and 
regulates TRPC1/4 heterotetramer channel activation and Ca2+ selectivity in lung 
endothelial cells (12). The current study investigated Orai1 as a candidate ion channel in 
mediating cholesterol-dependent endothelial SOCE. We found that either pharmacological 
inhibition or gene silencing of Orai1 significantly decreased endothelial SOCE, 
demonstrating that Orai1 contributes to SOCE in both PAEC and PMVEC. Furthermore, 
AnCoA4-sensitive SOCE was abolished in PAEC from CH rats, suggesting that the 
reduction in SOCE following CH results from impaired Orai1 activity. Interestingly, our 
finding that cholesterol replenishment rescues Ca2+ entry in PAEC from CH rats suggests 
that altered expression of Orai1 or STIM1 does not explain this deficit, but rather regulation 
of Orai1 activity by the molecular composition of the membrane. Such influences of 
cholesterol may occur through direct interaction with Orai1 and STIM1, indirectly through 
regulation of caveolin-1 or other lipid raft components, or by altering Orai1/STIM1 
trafficking and membrane localization. 
Although AnCoA4 is characterized as a selective inhibitor of Orai1 (ref), whether 
AnCoA4 similarly inhibits Orai2 or Orai3 is unknown.  These related Ca2+ channel 
isoforms have been implicated as store-operated channels in a variety of cell types (16, 33, 
68, 77), and mediate SOCE when over-expressed with STIM1 in heterologous expression 
systems (48).  However, in contrast to the established contribution of Orai1 to SOCE in 
pulmonary endothelial cells, store-depletion induced Ca2+ entry is independent of Orai2 
and Orai3 in endothelial cells from several vascular beds (30, 74, 85). Furthermore, 
whether these channels are expressed and play a functional role in PAECs remains to be 
established. Therefore, while we cannot exclude a possible inhibitory effect of AnCoA4 on 
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Orai2 or Orai3 in the present study, the similar effects of AnCoA4 and Orai1 siRNA to 
inhibit SOCE are supportive of a contribution of Orai1 to this response. 
Cholesterol may modulate the function of membrane proteins via either direct 
interaction or through altering the properties of lipid microdomains (38). Several groups 
have reported that membrane cholesterol depletion by MβCD attenuates SOCE in a variety 
of cell types (14, 20, 24, 29, 59). Interestingly, however, recent reports by Derler et al (13) 
and Pacheco et al (55) reported cholesterol-binding sites on Orai1 and STIM1, respectively, 
and demonstrated an inhibitory effect of membrane cholesterol on SOCE in cultured 
human embryonic kidney 293 cells and rat basophilic leukemia 2H3 cells. Both studies 
further showed that the cholesterol-Orai1 and cholesterol-STIM1 interaction was 
attenuated by mutating the cholesterol-binding site of the target protein. Although many 
studies have employed the cholesterol-depleting agents MβCD or filipin to evaluate 
functional roles for membrane cholesterol, an important limitation of these agents is that 
they may exert off-target effects by disrupting caveolar stucture, thereby altering 
biophysical properties of the plasma membrane (2, 61, 84). Thus, these approaches may 
interrupt SOCE in a non-specific manner unrelated to direct interaction of membrane 
cholesterol with ion channels, which may limit the interpretation of how cholesterol 
regulates SOC. In our current studies, we substituted endogenous cholesterol with Epichol, 
an approach that alters membrane cholesterol content without disrupting caveoli (84), and  
found that cholesterol is required for Orai1-mediated SOCE in both isolated PAEC and 
cultured PMVEC. We also showed that Epichol substitution significantly reduced the 
STIM1-Orai1 interaction, suggesting that membrane cholesterol regulates endothelial 
SOCE by facilitating this interaction that is required for Orai1 activation. The reason for 
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the conflicting observations of how membrane cholesterol regulates SOCE in our current 
studies and those of other groups (13, 55) is not clear, but may be due to heterogeneity 
between either different cell types or between transfected/cultured cells and native 
endothelial cells. Additionally, since SOCE is a complex muti-step signaling pathway, it is 
also possible that membrane cholesterol affects components of SOCE differently. Galan et 
al and Pani et al (20, 59) suggested that membrane cholesterol is required for STIM1 
oligmerization and subsequent interaction with and activation of Orai1. After the STIM1-
Orai1 complex is formed, however, cholesterol may inhibit SOCE through direct 
interaction with Orai1 and STIM1 (13, 20, 55). Additional experiments are required to 
investigate if membrane cholesterol directly regulates endothelial STIM1 clustering, 
STIM1-Orai1 interaction, and Orai1 activation in PAECs.   
Although our studies indicate that membrane cholesterol plays a functional role in 
Orai1-mediated SOCE in pulmonary endothelial cells, these findings do not preclude a 
potential role for cholesterol to regulate TRPC channels independent of Orai1 and STIM1. 
Despite a lack of evidence for direct regulatory cholesterol binding sites on TRPC channel 
sequences, the membrane cholesterol sensitivity of TRPC channels has been reported in 
several cell types (1, 6, 37, 50, 81). For example, the extraction of membrane cholesterol 
by cyclodextrins impairs TRPC1 signaling processes (6, 42). Although cholesterol may 
play a pivotal regulatory role in TRPC1-mediated SOCE by regulating membrane 
structure, direct effects of cholesterol on TRPC functions are possible.  
Our studies also suggest that loss of membrane cholesterol contributes to impaired 
endothelial SOCE in CH-induced pulmonary hypertension (84). Due to the limitation of 
the filipin staining approach to detect oxidized cholesterol (63), reduced membrane 
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cholesterol following CH is possibly the result of impaired cholesterol de novo synthesis 
(54), oxidative modification of cholesterol (52) or decreased membrane cholesterol 
trafficking. Nguyen et al (54) have explored the mechanism by which hypoxia affects de 
novo cholesterol biosynthesis. They reported that hypoxia induces accumulation of 
cholesterol biosynthetic intermediates and rapid degradation of HMG-CoA reductase, 
which contribute to a reduction of cholesterol production. Given the importance of reactive 
oxygen species to the development of CH-induced pulmonary hypertension (19, 26, 27, 
41), endothelial dysfunction in this setting may alternatively result from oxidative 
modifications to cholesterol that alter membrane lipid domains and interfere with ion 
channel function.    
Based on our findings that CH attenuates pulmonary endothelial Ca2+ entry by 
depleting membrane cholesterol, it may be predicted that targeted depletion of PAEC 
cholesterol would minimally or adversely affect the development of PH in this setting. In 
apparent contrast to this prediction, HMG-CoA reductase inhibitors (statins) have 
demonstrated beneficial effects in attenuating the development of CH-induced pulmonary 
hypertension in animal models (23, 36, 49). However, the mechanisms by which statins 
mediate this protective influence are thought to be independent of their cholesterol 
lowering properties (10, 46, 70, 78, 80). These include inhibition of RhoA that can not only 
decrease vascular smooth muscle contractility (76), proliferation and migration (79), but 
also increase eNOS expression and activity (70). Additional evidence suggests that statins 
increase NO production by inhibiting expression and activity of NADPH oxidase subunits, 
and thus production of endothelial reactive oxygen species (44, 78, 80), rather than through 
effects on endothelial cholesterol content. Such non-specific effects of statins likely result 
107 
 
from decreased production of intermediates of the mevalonate pathway that are necessary 
for posttranslational modification of many signaling proteins (7). In contrast to these 
animal studies, however, clinical trials of statin therapy in patients with pulmonary arterial 
hypertension have been largely inconclusive (66).  
In conclusion, the current study demonstrates a novel effect of membrane 
cholesterol to regulate pulmonary endothelial SOCE by facilitating the interaction of 
STIM1 and Orai1 (Figure 8). These observations advance our basic understanding of how 
membrane cholesterol regulates endothelial [Ca2+]i homeostasis, and have potentially 
broader implications for cholesterol-dependent regulation of a wide range of vasoactive 
and mitogenic pathways. These findings may additionally provide a mechanistic basis to 
explain the CH-induced diminution of endothelial Ca2+ influx and associated endothelial 
dysfunction that is central to the pathogenesis of pulmonary hypertension.  Challenges of 
future studies are to identify the potential contribution of reactive oxygen species to 
decreased endothelial cholesterol following CH, either through direct cholesterol oxidation 
or impaired sterol trafficking, and the contribution of these responses to increased 
vasoconstrictor reactivity, arterial smooth muscle mitogenesis, and the development of 
pulmonary hypertension.  
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Figure 1. Impaired pulmonary endothelial store-operated Ca2+ entry (SOCE) following 
chronic hypoxia (CH) is restored by cholesterol supplementation. Cyclopiazonic acid 
(CPA)-induced Ca2+ entry was assessed by Mn2+ quenching technique in freshly isolated 
pulmonary artery endothelial cell (PAEC) sheets from control and CH rats. Cells were pre-
treated with vehicle, cholesterol (Chol), or epicholesterol (Epichol). F, fluorescence 
intensity at 360 nm excitation; F0, fluorescence intensity at time zero. A) SOCE in PAEC 
from normoxic rats.; n = 5-8 animals/group. *P <0.05 vs. Veh and Chol over the range of 
30 - 120 s. B) SOCE in PAEC from CH rats. n = 4-8 animals/group. *P <0.05 vs. Veh and 
Epichol over the range of 60 - 120 s. C) SOCE in PAEC from each group 120 s after onset 
of quenching. *P <0.05 vs. Nor Vehicle; #P <0.05 vs. CH Vehicle. Values are means ± SE. 
A One-way ANOVA (A,B) or two-way ANOVA (C) followed by the Student-Newman-
Keuls test were used to compare between groups. 
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Figure 2. Orai1 mediates pulmonary endothelial SOCE. A) AnCoA4 inhibits SOCE but 
not depolarization-induced Ca2+ entry in freshly dispersed PAEC from normoxic rats. B) 
AnCoA4 attenuates SOCE but not OAG (diacylglycerol analog)-induced Ca2+ entry in 
cultured pulmonary microvascular endothelial cells (PMVEC).  An unpaired t-test was 
used to compare between groups at 120 s after onset of quenching. *P < 0.05 vs. Veh CPA. 
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Figure 3. Membrane cholesterol-sensitive Orai1 contributes to impaired SOCE in PAEC 
following CH. A) SOCE was assessed in PAEC from normoxic and CH rats pretreated 
with either the Orai1 inhibitor, AnCoA4, or vehicle. n = 6, Nor Veh; n = 8, CH Veh; n = 
5, Nor AnCoA4; n = 4, CH AnCoA4. *P < 0.05 vs. Nor-Veh over the range of 40 - 120 s.  
Effects of AnCoA4 on SOCE (120s after onset of quenching) in freshly dispersed PAEC 
from normoxic (B) and CH (C) rats following membrane cholesterol manipulation.  *P 
<0.05 vs. Veh within groups; #P <0.05 vs. Veh-Vehicle.   
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Figure 4. Epicholesterol reduces endogenous membrane cholesterol content of cultured 
PMVEC. A) Representative images of filipin fluorescence from PMVEC treated with 
vehicle, MβCD, cholesterol, or epicholesterol. B) Mean filipin fluorescence (arbitrary 
units; A.U.) in PMVEC from each group. Data were compared by the Kruskal-Wallis H 
test and Dunn’s multiple comparison test. n = 5 (filipin fluorescence of 4-16 cells were 
measured per field of interest and averaged for an n=1). *P < 0.05 vs. Vehicle; #P <0.05 
vs. MβCD and Epichol. C) Amplex Red cholesterol assay to detect cholesterol 
concentration in PMVEC. Data were compared by one-way ANOVA followed by the 
Student-Newman-Keuls test. n = 3. *P < 0.05 vs. Vehicle; #P <0.05 vs. MβCD and Epichol. 
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Figure 5. Epicholesterol substitution reduces SOCE in PMVEC pretreated with 
cholesterol. n = 5, Chol; n = 5, Epichol; n = 3, Time Control. *P < 0.05 vs. Chol over the 
range of 50 - 120 s. 
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Figure 6. Orai1 siRNA knockdown inhibits membrane cholesterol-dependent SOCE in 
PMVEC. A) Representative western blot of Orai1 and β-actin protein bands in PMVEC 
transfected with Orai1 siRNA or non-targeting (NT) siRNA. B) Mean western blot data of 
Orai1 expression from NT and Orai1 siRNA treated PMCEC. Orai 1 levels are normalized 
to those of β-actin. n = 4 /group. *P < 0.05 vs. NT. C) SOCE in cultured PMVEC. n = 3-4 
/group. *P < 0.05 vs. NT+Chol over the range of 60 - 120 s. 
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Figure 7. Epicholesterol substitution reduces STIM1-Orai1 interaction in PMVEC as 
assessed by in situ proximity ligation assay. A) Representative images of STIM1-Orai1 
interactions (red puncta) in response to CPA in cultured PMVEC with manipulated 
membrane cholesterol. Nuclei area labeled with SYTOX (green). B) Summarized data of 
STIM1-Orai1 interaction expressed as average number of puncta/cell in cultured PMVEC. 
Cholesterol supplementation increased the CPA-induced STIM1-Orai1 interaction, 
whereas epicholesterol substitution significantly inhibited this response. Groups were 
compared by two-way ANOVA followed by multiple comparisons testing using the 
Student-Newman-Keuls test. n = 5/group.  *P <0.05 vs. Chol Veh; #P <0.05 vs. Chol CPA. 
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Figure 8. Proposed mechanism by which reduced cell membrane cholesterol (Chol) 
following CH attenuates SOCE in PAECs. Cholesterol facilitates the interaction of STIM1 
and Orai1 in response to depletion of intracellular Ca2+ stores, e.g. by receptor (R)-
mediated activation of inositol trisphosphate receptors (IP3R), or inhibition of the 
sarco/endoplasmic reticulum Ca2+ -ATPase (SERCA). CH inhibits this mechanism by 
depletion of cell membrane cholesterol. Endoplasmic reticulum (ER), agonist (A). 
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CHAPTER 4: DISCUSSION 
The goal of this dissertation was to investigate the role of membrane cholesterol in 
pulmonary endothelial Ca2+ entry in CH-induced pulmonary hypertensive rats. In the 
current studies we tested the hypotheses that 1) membrane cholesterol facilitates SOCE 
and depolarization-induced pulmonary endothelial Ca2+ entry; 2) membrane cholesterol 
regulates Orai1-mediated SOCE through facilitating STIM1-Orai1 interaction, and 3) 
reduced endothelial Ca2+ influx following CH is due to a loss of membrane cholesterol. 
We identified the role of membrane cholesterol in regulating agonist-induced Ca2+ entry 
and its components in PAECs following CH through measurement of [Ca2+]i  using a 
ratiometric fluorescent Ca2+ indicator in live cells with cholesterol supplementation or 
substitution of cholesterol with its epimer, epicholesterol. The rationale behind these 
studies emerges from the observation in CH-induced PH that dysregulation of 
endothelium-derived mediators contributes to elevated vascular resistance in the 
pulmonary circulation. The production of many endothelium-derived vasodilators and anti-
mitogenic substances like NO (18, 39, 89, 102) and prostacyclin (60, 144) are largely a 
function of endothelial [Ca2+]i. Therefore, it is possible that reduced endothelial [Ca
2+]i 
limits the production of NO, prostacyclin, and other endothelium-derived hyperpolarizing 
factors. Our laboratory previously reported that both basal [Ca2+]i and agonist-induced Ca
2+ 
influx are lower in PAECs from CH rats compared to their normoxic controls (95). Both 
endothelial SOCE and depolarization-induced Ca2+ entry through T-type VGCCs, two 
major components of ATP-induced Ca2+ influx, are also reduced following CH exposure 
(94, 96). Interestingly, membrane cholesterol levels along with the agonist-induced Ca2+ 
entry are decreased in PAECs of chronic hypoxic rats. This impaired Ca2+ influx is restored 
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simply by either membrane cholesterol supplementation or administration of caveolin-1 
scaffolding domain peptide (95). Because membrane cholesterol and caveolin-1 are major 
structural components of caveolae, the diminished Ca2+ influx could be the result of 
decreased caveolae after CH. However, the number of caveolae are not altered in PAECs 
from CH rats compared to controls (95). These observations suggest a role of membrane 
cholesterol in mediating endothelial Ca2+ influx.  
The major findings from the current studies are that substitution of endogenous 
membrane cholesterol with epicholesterol attenuates ATP-induced Ca2+ entry, SOCE and 
depolarization-induced Ca2+ entry in PAEC. In addition, decreased endothelial SOCE and 
depolarization-induced Ca2+ entry following CH are largely restored by cholesterol 
supplementation. Importantly, neither cholesterol supplementation nor epicholesterol 
substitution alters endothelial caveolar number. In addition, membrane cholesterol 
regulates Orai1-mediated SOCE in both native and cultured cells. Epicholesterol 
substitution greatly reduces SOCE and STIM1-Orai1 interaction in cultured PMVECs. 
These data suggest that membrane cholesterol directly regulates agonist-induced Ca2+ entry 
and its components. These observations also demonstrate that altered membrane 
cholesterol homeostasis may contribute to impaired endothelial Ca2+ entry following CH.  
Effect of hypoxia on pulmonary endothelial [Ca2+]i 
The mechanisms by which hypoxia affects endothelial [Ca2+]i are not well-
investigated. Studies investigating the effect of acute hypoxia on endothelial [Ca2+]i in vitro 
show similar results in cells from the systemic and pulmonary vasculatures. In human 
umbilical vein endothelial cells (HUVEC) (6, 11), as well as in bovine (53) and porcine 
(58) PAECs, acute hypoxia increases endothelial [Ca2+]i. The significant increase of [Ca
2+]i 
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in HUVECs is due to energy deficiency and subsequent influx of extracellular Ca2+ (6). 
Berna et al (11) later discovered that the Na+/ Ca2+ exchanger is involved in this hypoxia-
induced Ca2+ influx. By using an inhibitor of Na+-glucose cotransport, they proposed that 
energy deficiency activates glycolysis and subsequent activation of Na+-glucose 
cotransport, which leads to a series of actions including Na+ influx, Na+/ Ca2+ exchanger 
activation, and Ca2+ influx. In PAECs, however, although acute hypoxia (5 min) causes a 
rapid and transient increase in [Ca2+]i by releasing Ca
2+ from ER stores (53), a longer 
duration of hypoxia (15 min) decreases [Ca2+]i likely by causing membrane depolarization 
and reducing the electrochemical driving force for Ca2+ entry (124). While it is certainly 
possible that hypoxia has a dual-phase effect of releasing Ca2+ from internal stores and 
inhibiting Ca2+ influx in bovine PAECs, it should be noted that Hampl et al (53) used 
bovine cells of high passage (16-25), whereas Stevens et al (124) used primary bovine 
PAECs. The increased passage number of cells may cause changes in ion channel 
expression and activity (55, 70). In rat PAECs, for example, although T-type VGCCs are 
not found in cultured cells (145), their expression and function are described in freshly 
dispersed PAECs (96). This difference may lead to opposite effects of hypoxia on 
endothelial Ca2+ entry, as hypoxia-induced membrane depolarization may blunt Ca2+ influx 
driven by electrochemical gradient in cultured PAECs while increasing Ca2+ entry through 
T-type VGCCs in native PAECs. 
In human PAEC, prolonged exposure to hypoxia (3% O2, 60-72h) causes an 
increase in basal [Ca2+]i, which is due to enhanced expression of TRPC-encoded SOC 
channels and Ca2+ influx (53). However, it is possible that exposure of hypoxia to cultured 
cells may not mimic the in vivo effect of CH on PAECs. It is also likely that CH impairs 
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the regulation of pulmonary endothelial [Ca2+]i as PH develops. Murata et al (87) showed 
that in 1 week CH-induced pulmonary hypertensive rats, agonist-induced Ca2+ influx in the 
pulmonary endothelium is significantly less compared to normoxic control rats. 
Consistently, in rats exposed to 4 weeks CH, our previous data demonstrate that, in PAECs, 
both basal [Ca2+]i and agonist-induced Ca
2+ influx with its major components, SOCE and 
depolarization-induced Ca2+ influx through T-type VGCCs, are lower compared to those 
of normoxic control animals (94–96). In addition, membrane cholesterol levels are also 
reduced in PAEC from rats exposed to CH. The most exciting discovery is that the impaired 
agonist-induced Ca2+ influx in PAEC can be restored by both membrane cholesterol 
supplementation and by administration of a caveolin-1 (Cav-1) scaffolding domain peptide 
(95). This finding suggests that the reduced endothelial agonist-induced Ca2+ influx 
following CH is not likely due to reduced expression of the relevant Ca2+ channels. In the 
current studies, we found that the diminished SOCE and depolarization-induced Ca2+ 
influx can also be restored by membrane cholesterol supplementation (Figure 5 and 9: 
Chapter 3). These data suggest that cholesterol per se may affect Ca2+ entry in these cells. 
By using epicholesterol, we also determined that cholesterol directly modulates endothelial 
agonist-induced Ca2+ entry, SOCE and depolarization-induced Ca2+ entry independent of 
its structural role in the plasma membrane, which will be discussed later in “Membrane 
cholesterol: structural component vs. signaling mediator”.  
Although we did not examine the change of [Ca2+]i in early stages of CH-induced 
PH, it is possible that hypoxia augments Ca2+ influx and [Ca2+]i in PAEC during the early 
stages of hypoxic exposure (135). However, after prolonged hypoxia, endothelial Ca2+ 
entry may be gradually diminished due to altered cholesterol homeostasis, leading to 
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decreased [Ca2+]i in PAECs. The finding that reduced endothelial Ca
2+ entry in pulmonary 
arteries following CH was acutely restored by membrane cholesterol supplementation 
suggests that CH limits Ca2+ entry in PAECs by reducing membrane cholesterol rather than 
by decreasing ion channel expression. The physiological consequences of these changes in 
pulmonary endothelial Ca2+ influx and [Ca2+]i will be discussed in detail later in 
“Physiological significance of current studies”. 
 
Pulmonary endothelium-mediated vasodilation following CH 
The results of our current and previous studies (94) show that agonist-induced Ca2+ 
entry as well as basal [Ca2+]i are reduced in PAECs following CH. Although we did not 
examine the physiological consequences of decreased pulmonary endothelial [Ca2+]i, the 
reduction of [Ca2+]i may limit the synthesis and release of vasodilators such as NO, which 
would impair endothelium-dependent vasodilation in pulmonary arteries. However, 
opposite to this assumption, early studies from our and other laboratory demonstrated that 
CH enhances pulmonary artery endothelium-derived nitric oxide (EDNO)-dependent 
vasodilation (32, 59, 108, 115). In these studies using isolated perfused lungs, there was an 
increase in AVP/histamine/ET-1-induced EDNO-dependent vasodilation in rats exposed 
to 4 weeks of CH (32, 108). However, CH did not affect the vasodilation to an exogenous 
NO donor, suggesting that the change of agonist-induced vasodilatory responses after CH 
was due to reduced bioavailability of NO. Later studies also found that eNOS protein 
expression is elevated in CH rats compared to their normoxic controls (107). Thus, the 
apparent contradictory observation of impaired pulmonary endothelial [Ca2+]i and 
augmented EDNO-dependent vasodilation following CH warrants discussion.  
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Because endothelium-derived NO is the result of multiple signaling cascades 
involving Ca2+-dependent and Ca2+-independent pathways, receptor stimulation by 
agonists may lead to NO production through different mechanisms. In addition, since the 
production of other endothelium-derived vasodilators like prostacyclin and EDHF are also 
closely regulated by endothelial [Ca2+]i (56, 79, 117), NO may not fully responsible for 
agonist-induced endothelium-dependent vasodilation. The receptors responsible for 
AVP/histamine/ET-1 -induced EDNO are mainly V1-receptors (114)/H1 and H2-receptor 
(115, 126)/ETB receptors (33). V1-receptors, H1-receptors, and ETB receptors are Gq-
protein coupled receptors (27, 69, 127, 128), the activation of which leads to Ca2+ entry 
though similar pathways as ATP-induced Ca2+ influx described in the introduction. V2- 
and H2-receptors are Gs-protein coupled receptors that may be involved in NO production 
through Ca2+-independent mechanisms (65, 66). The stimulation of Gs-protein coupled 
receptors activates adenylyl cyclase and subsequently produces cyclic AMP (cAMP) from 
ATP. cAMP may phosphorylate eNOS-Ser (bovine eNOS-Ser1179 or human eNOS-Ser1177) 
through AMP-activated protein kinase (22) or protein kinase B (PKB) (149) signaling 
pathways. Phosphorylation of eNOS-Ser increases the activity of eNOS by reducing the 
relative requirement of Ca2+ for its activation, which is achieved by increasing the rate of 
electron flux from the reductase to the oxygenase domain of the protein and reduces (82). 
Thus, with multiple signaling pathways leading to vasodilation, the physiological effect of 
reduced agonist-induced Ca2+ entry after CH may not be reflected when potential 
compensatory mechanisms are present. In fact, H2-receptor -mediated vasodilatory 
responses to histamine were augmented in the pulmonary circulation following CH (115). 
Besides, since EDHF also mediates histamine-induced vasodilation in the pulmonary 
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circulation (54), it is also possible that this vasodilatory pathway is augmented after CH, 
which may explain why non-EDNO-mediated vasodilation by histamine was increased 
after CH (108).  
Despite the potential compensatory mechanisms by which CH increases agonist-
induced NO production and vasodilation, Ca2+-dependent EDNO production may still be 
increased as a result of enhanced expression of eNOS (107) and receptors for agonists (122) 
in PAECs from CH rats. Because endothelial ROS production is elevated following CH 
(62), enhanced Ca2+-dependent EDNO production may be a compensatory mechanism to 
increase NO bioavailability. In addition, based on studies by Murata et al (87), in rats 
exposed to 1 week chronic hypoxia, agonist-induced Ca2+ entry and NO production are 
significantly reduced in pulmonary endothelium while no change of eNOS expression is 
detected. The reduced NO production could be the result of both decreased Ca2+-dependent 
eNOS activation and impaired eNOS activity due to tight coupling of eNOS/caveolin-1. 
This evidence suggests that endothelial Ca2+ entry and associated NO production are 
impaired in the early stage of CH-induced PH, which may activate potential compensatory 
mechanisms that increase agonist-induced EDNO production.  
 
Membrane cholesterol: structural component vs. signaling mediator 
The role of membrane cholesterol in regulating ion channel function has received 
considerable attention during the last decade. It is now well-accepted that cholesterol is a 
crucial regulator of various ion channels and plays different roles depending on the type of 
ion channel. In general, membrane cholesterol may decrease the number of active channels 
or the activity of several K+ channels, voltage-gated Na+ and Ca2+ channels, and volume-
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regulated anion channels (25, 74, 112, 130). However, other ion channels such as the 
nicotinic acetylcholine receptor, GABAA receptors, epithelial Na
+ channels and TRPC 
channels are inhibited by removal of membrane cholesterol (8–10, 71, 123). These dynamic 
roles of membrane cholesterol in regulating ion channel function are possibly achieved 
through two mechanisms: 1) indirect regulation by altering the properties of lipid 
microdomains; and 2) direct interaction with ion channels. The first mechanism was 
proposed by Lundbaek et al (78) that membrane cholesterol may affect ion channels by 
modulating bilayer stiffness and hydrophobic interactions between membrane proteins and 
the lipid bilayer. The stiffer membrane may lead to increased membrane deformation 
energy that affects the conformational change of ion channels when transitioning between 
open and closed states (78). A change in the lipid bilayer properties may also affect other 
signaling cascades within the lipid raft microdomains, which could indirectly modulate ion 
channel function. The concept of direct interaction between cholesterol and ion channels 
was first proposed by Marsh and Barrantes in a “lipid belt” model (78). The direct 
interaction between membrane cholesterol and ion channels was not demonstrated until the 
use of the enantiomer of the sterol, epicholesterol (111) and the identification of a 
cholesterol binding motif in several ion channels (30, 113, 120). Considering that direct 
and indirect effects of cholesterol on ion channels may exist simultaneously, discrimination 
between these two possibilities is challenging but important when exploring the 
mechanisms of cholesterol regulation of ion channels. 
Many studies have shown that membrane cholesterol is important in regulating Ca2+ 
channels and that its effects on Ca2+ influx are diverse (14, 17, 104). In HSG and HEK293 
cells, cholesterol depletion by MβCD blunts SOCE by suppression of STIM1 clustering 
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and activation of TRPC1 (97). In VSMCs, MβCD also reduces endothelin-1-induced Ca2+ 
entry through TRPC1 (10). Our previous and current findings showed that, in PAECs, 
agonist-induced Ca2+ influx along with membrane cholesterol levels are reduced following 
CH (95, 148). This impaired endothelial Ca2+ influx was restored by membrane cholesterol 
supplementation (95, 148). Our current studies also show that cholesterol directly 
modulates endothelial agonist-induced Ca2+ entry and its major components, SOCE and 
depolarization-induced Ca2+ entry. The direct functional effect of cholesterol was examined 
by replacing cholesterol with its enantiomer, epicholesterol, that has similar effects on 
membrane fluidity and lipid domain formation but differential effects on ion channel 
function. We found that substitution of endogenous membrane cholesterol with its epimer 
attenuates ATP-induced Ca2+ entry, SOCE and depolarization-induced Ca2+ entry in PAEC 
(Figure 4, 5 and 9: Chapter 3). In addition, decreased endothelial SOCE and 
depolarization-induced Ca2+ entry following CH are largely restored by cholesterol 
supplementation (Figure 5 and 9: Chapter 3). These data suggest that membrane 
cholesterol directly regulates agonist-induced Ca2+ entry and its components and further 
demonstrate that impaired endothelial Ca2+ entry following CH is due to altered membrane 
cholesterol homeostasis. 
It should be noted that the rationale of using epicholesterol in this aim is based on the 
assumption that epicholesterol should have very similar effects to cholesterol on the 
physical properties of the plasma membrane but interact with Ca2+ channels differently. 
Our observation that neither cholesterol supplementation nor epicholesterol substitution 
alters endothelial caveolar number (Figure 2: Chapter 3) support this rationale. However, 
although other studies also showed that cholesterol and epicholesterol have similar effects 
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on membrane fluidity (46) and lipid domain formation (146), these two sterols may still 
have differential effects on the properties of plasma membrane (28, 29, 84). Parallel studies 
using the other enantiomer, ent-cholesterol that differs from cholesterol in the 
configuration of each of the eight stereocenters, might provide additional insight to how 
membrane cholesterol directly modulates pulmonary endothelial Ca2+ entry. 
 
Caveolae, caveolin-1, and membrane cholesterol regulation of Ca2+ channels 
Caveolae are small (50-100 nm) invaginations of the plasma membrane that are rich 
in cholesterol and the structural protein Cav-1. They are one type of lipid raft with dynamic 
assemblies of proteins, ion channels, and high levels of cholesterol and glycosphingolipids. 
Due to their unique characteristics as a platform for various signaling molecules, caveolae 
regulate many signaling pathways, including Ca2+ entry. In fact, Ca2+ signaling 
components such as G-protein coupled receptors, PLC, IP3R, and SOC are found in lipid 
raft domains/caveolae (15, 43, 86, 99). Both TRPC1 and 4, as SOCs, are not only located 
in caveolae, but also interact with Cav-1, which is crucial for SOCE (15, 86).  
Cav-1, as one of three isoforms of caveolin, is abundantly expressed in endothelial 
cells (116). Cav-1 is localized to caveolae and serves as one of the basic structural 
components of caveolae (36, 106). Besides its structural role in caveolar formation, Cav-1 
also plays a regulatory role in mediating Ca2+ influx, as suggested by studies using mutated 
Cav-1 in cultured cells or Cav-1 knockout mice indicating that Cav-1 is required for SOCE 
by interacting with Ca2+ channels (15, 86). Thus, similar to membrane cholesterol, Cav-1 
may regulate endothelial Ca2+ influx through its structural modulation of caveolae and its 
functional interaction with ion channels. What makes the interpretation of how Cav-1 
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affects endothelial Ca2+ influx more complicated is that Cav-1 may also regulate cholesterol 
homeostasis via cholesterol influx/efflux and intracellular trafficking (38, 40, 151). As 
reported in our previous studies (95), agonist-induced Ca2+ entry is diminished in PAECs 
of CH rats and can be restored to levels of normoxic controls by either cholesterol 
supplementation or administration of the Cav-1 scaffolding domain peptide, AP-Cav. 
Because there is no change of caveolae number in pulmonary endothelium after CH 
exposure (95), any structural changes in caveolae may have minimal effects on endothelial 
Ca2+ channel function. Based on the findings of our current studies, membrane cholesterol 
may directly regulate Ca2+ channels or signaling pathways leading to channel activation. 
Because indirect measurements of Cav-1 expression by immunofluorescence labeling 
show no obvious changes in Cav-1 levels after CH (95), AP-Cav may restore the 
diminished endothelial Ca2+ influx in CH rats by facilitating cholesterol trafficking from 
ER lipid droplets to the plasma membrane. This potential mechanism of ion channel 
regulation is supported by studies of Toselli et al (130). They found that Cav-1-transfected 
NG108-15 cells have increased membrane cholesterol content and significantly reduced 
N-type Ca2+ current compared to wild-type control. This effect was mimicked in wild-type 
cells by cholesterol supplementation, suggesting that membrane cholesterol, not Cav-1, is 
required for N-type Ca2+ channel inhibition.  
Nevertheless, with evidence that Cav-1 may interact with large conductance, Ca2+-
activated K+ channels (BK) (136), we cannot exclude the possibility that Cav-1 may also 
directly modulate certain Ca2+ channels function in PAEC. Besides, membrane cholesterol 
not only regulates Cav-1 expression (52) but also affects Cav-1 trafficking between the 
plasma membrane and Golgi apparatus (101, 121). Membrane cholesterol may also help 
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stabilize Cav-1 on the plasma membrane (41). Thus, membrane cholesterol may indirectly 
affect endothelial Ca2+ influx through regulation of Cav-1 expression and trafficking. This 
regulation of Cav-1 by membrane cholesterol may be observed in PASMC, in which both 
SOCE and ROCE, as well as agonist-induced contraction in pulmonary artery rings are 
augmented due to increased Cav-1 following CH (63). These Ca2+ entry pathways appear 
to be independent of membrane cholesterol as cholesterol supplementation does not 
increase these responses. The disruption of caveolae by MβCD, however, inhibits all Ca2+ 
responses, potentially through reduction of cholesterol-mediated surface expression of 
Cav-1. Considering the regulatory effect of membrane cholesterol and Cav-1 on each other, 
it is very likely that both components of caveolae are involved in the changes of pulmonary 
endothelial Ca2+ homeostasis during CH exposure.  
 
Cholesterol regulation of STIM1, Orai1, and TRPC. 
The essential role of membrane cholesterol in regulating SOCE has been shown in 
many cell types as membrane cholesterol depletion by MβCD attenuates SOCE (31, 45, 51, 
64, 97). In the present studies, we substituted endogenous cholesterol with epicholesterol, 
and found that cholesterol is required for Orai1-mediated SOCE in both isolated PAEC and 
cultured PMVEC. We also showed that epicholesterol substitution significantly reduced 
the STIM1-Orai1 interaction, suggesting that membrane cholesterol regulates endothelial 
SOCE by facilitating this interaction that is required for Orai1 activation. Interestingly, 
Derler et al (30) and Pacheco et al (93) reported cholesterol-binding sites on Orai1 and 
STIM1, respectively, and demonstrated an inhibitory effect of membrane cholesterol on 
SOCE in cultured human embryonic kidney 293 (HEK293) cells and rat basophilic 
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leukemia 2H3 cells. Both studies further showed that the cholesterol-Orai1 and cholesterol-
STIM1 interaction was attenuated by mutating the cholesterol-binding site of the target 
protein. The reason for the conflicting observations of how membrane cholesterol regulates 
SOCE in our current studies and those of other groups (30, 93) is not clear, but may be due 
to heterogeneity between either different cell types or between transfected/cultured cells 
and native endothelial cells. Additionally, since SOCE is a complex multi-step signaling 
pathway, it is also possible that membrane cholesterol affects components of SOCE 
differently. Galan et al (45) showed that membrane cholesterol depletion by MβCD 
attenuates SOCE and STIM1-Orai1 association in HEK293 cells. However, if stores are 
depleted prior to MβCD treatment, SOCE is enhanced while STIM1-Orai1 association 
remain unaffected by cholesterol depletion. Pani et al (97) found that MβCD treatment 
attenuates store depletion-induced STIM1 clustering and SOCE. Together, these findings 
suggest that plasma membrane cholesterol is required for STIM1 oligmerization and 
subsequent interaction with and activation of Orai1. Whether the cholesterol regulation of 
STIM1 clustering is achieved through maintaining caveolar structure or direct modulation 
of trafficking is not clear. However, since the silencing of Cav-1, which reduces the number 
of caveolae (26), does not affect STIM puncta formation in response to ER store depletion 
(98), it is possible that cholesterol on the plasma membrane or ER membrane directly 
affects STIM1 oligmerization. After the STIM1-Orai1 complex is formed, however, 
cholesterol may inhibit SOCE through direct interaction with Orai1 and STIM1 (30, 45, 
93).  
TRPC channels are also activated by stimuli that lead to PIP2 hydrolysis, and are 
identified as components of SOCE. Our current findings do not preclude a potential role 
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for cholesterol to regulate TRPC channels independent of Orai1 and STIM1. Despite a lack 
of evidence for direct regulatory cholesterol binding sites on TRPC channel sequences, the 
membrane cholesterol sensitivity of TRPC channels has been reported in several cell types 
(1, 10, 73, 86, 140). For example, the extraction of membrane cholesterol by cyclodextrins 
impairs TRPC1 signaling processes (10, 77). In addition, both TRPC1 and TRPC4 are 
expressed in murine lung endothelial cells (86). In these cells, Cav-1 regulates the 
subcellular distribution of TRPC1 and 4 to a low-density cholesterol-enriched membrane 
fraction. Cav-1 has also been shown to modulate surface expression of TRPC1 in cultured 
HSG cells (98). In endothelial cells from endothelium-specific Cav-1 knockout mice, 
SOCE is significantly blunted, which is restored in cells from Cav-1 reconstructed mice 
(86). Considering the regulatory role of Cav-1 on cholesterol homeostasis, although 
cholesterol may play a pivotal regulatory role in TRPC1-mediated SOCE by regulating 
membrane structure, direct effects of cholesterol on TRPC trafficking and functions are 
possible. 
Cholesterol may regulate surface expression of many membrane-bound proteins and 
ion channels. It has been shown that endocytosis (13, 138), proteins distribution in 
membrane microdomains (129), and endosomal mobility (20) are closely associated with 
membrane cholesterol levels. In rat atrial myocytes, lowering of membrane cholesterol by 
MβCD enhances outward potassium current by recruiting Kv1.5 channels from recycling 
endosomes (7). In addition, the role of membrane cholesterol in ion channel surface 
expression may vary depending on the channel isoform (44). In our previous and current 
studies, CH significantly reduced membrane cholesterol in PAECs (95, 148). It is not clear 
if chronic hypoxia changes the surface expression of certain Ca2+ channels through 
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membrane cholesterol-regulated pathways. Current literature does, however, demonstrate 
the inhibitory effect of hypoxia on K+ channel trafficking to the plasma membrane (23, 90). 
With the possibility that cholesterol modulates trafficking of cation channels, whether the 
effect of cholesterol supplementation of restoring diminished Ca2+ entry in PAECs is 
achieved through facilitating Ca2+ channel surface expression remains to be determined. 
 
Potential Mechanisms of diminished membrane cholesterol by CH 
Dietary uptake of cholesterol and endogenous biosynthesis are two major sources of 
cholesterol for mammalian cells. Cholesterol is synthesized in the ER and cytoplasm from 
acetyl coenzyme A (acetyl-CoA) to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) in the 
initial steps (49). Then HMG-CoA is converted to mevalonic acid by the rate-limiting 
enzyme, HMG-CoA reductase, which is the target of cholesterol lowering drugs like statins 
(61). Mevalonic acid is converted to squalene, and then to lanosterol through multiple steps. 
An additional 19 steps are required before cholesterol is synthesized from lanosterol. After 
its synthesis, cholesterol is either transferred to the plasma membrane or is converted to 
cholesterol esters, which prevent over-accumulation of intracellular free cholesterol (19). 
Excessive cholesterol is also prevented by negative feedback control mechanisms, one of 
which involves rapid degradation of HMG-CoA reductase through ER membrane proteins 
known as insulin-induced gene (Insig) -1 and -2 (118). An accumulation of sterol in the 
ER membrane causes binding of HMG-CoA reductase to Insigs and subsequent 
ubiquitination of reductase to degradation (118). Two potential mechanisms of decreased 
membrane cholesterol following CH include: 1) inhibition of de novo cholesterol 
biosynthesis; and 2) membrane cholesterol oxidation. Mukodani et al. first reported that 
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hypoxia induces lipid accumulation and impairs cholesterol synthesis in cultured rabbit 
skin fibroblasts (83). The mechanism by which hypoxia affects cholesterol synthesis was 
later explored by Nguyen et al. (92), who reported that hypoxia induces both accumulation 
of cholesterol biosynthetic intermediates and activation of HIF1-α-mediated induction of 
Insigs. These two signaling pathways lead to rapid degradation of HMG-CoA reductase 
and subsequently limit synthesis of cholesterol (92). In addition, CH can also increase the 
production of reactive oxygen species (ROS) (42, 75), which may facilitate membrane 
cholesterol oxidation. Because filipin cannot be used to label oxidized cholesterol (103), it 
is possible that reduced filipin staining in PAECs of CH group is the result of membrane 
cholesterol oxidation by hypoxia-induced ROS. Cholesterol oxidation not only has 
potential to disrupt the interaction between cholesterol and ion channels and many 
regulatory proteins, but may also inhibit de novo cholesterol synthesis (88). In addition, 
cholesterol oxidation causes Cav-1 accumulation in the Golgi apparatus (121), which may 
contribute to impaired Ca2+ channel function. With very limited evidence of how 
cholesterol oxidation by ROS may lead to endothelial dysfunction in pulmonary arteries, 
future studies are required to evaluate the potential contributions of this mechanism to 
reduced PAEC membrane cholesterol and Ca2+ entry following CH. 
 
Membrane cholesterol and hypercholesterolemia 
In addition to effects on serum cholesterol, hypercholesterolemia also leads to the 
increase of membrane choleterol levels of vascular endothelial cells (34), smooth muscle 
cells (21), and erythrocytes (131). Studies suggest that hypercholesterolemia increases 
[Ca2+]i of VSMCs and augments contraction (24, 142). Increased [Ca
2+]i of VSMCs could 
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be the result of excessive membrane cholesterol in hypercholesterolemia, as suggested by 
studies looking into the effect of cholesterol enrichment on basal and agonist-induced Ca2+ 
entry in these cells (12, 48). Augmented sensitivity of VSMCs to contractile stimuli may 
also be associated with ROS produced during hypercholesterolemia (109, 125). 
Meanwhile, hypercholesterolemia is also reported to impair endothelium-dependent 
relaxation (119, 147), which may also be caused by excessive membrane cholesterol added 
during hyperchoelsterolemia that reduces SOCE, eNOS phosphorylation, and NO 
production (4).  
However, our current observation that cholesterol supplementation rescues blunted 
endothelial Ca2+ entry in PAEC from CH rats suggests a different role of cholesterol in 
regulating Ca2+ entry pathways. Although it is reported that CH does not affect total 
cholesterol levels in blood of pulmonary hypertensive rats (85), our studies do show the 
reduction of both serum cholesterol (unpublished data) and membrane cholesterol in 
PAECs after CH exposure (95, 148). This observation generates an interesting question of 
whether inhibition of cholesterol synthesis by HMG-CoA reductase inhibitors may mimic 
the effect of CH in reducing Ca2+ entry in PAECs. Rather, studies from other groups using 
statins, HMG-CoA reductase inhibitors to treat hypercholesterolemia, demonstrate a 
beneficial effect of this cholesterol-lowering drug in attenuating the development of CH-
induced PH (47, 85). Statins could promote endothelial function through several 
mechanisms (80). For example, statin treatment may restore the reduced endothelial NO 
through multiple mechanisms including increasing eNOS expression (72), enhancing 
eNOS activity (37, 85), or antioxidant effects (134, 139). Studies also suggests that, by 
decreasing cholesterol synthesis and Cav-1 expression, statins reduce the inhibitory effect 
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of caveolin on eNOS and enhance NO release (37). Since chronic treatment of statins does 
not reduce NO production and endothelium-dependent vasodilatory responses to agonist 
under normoxic conditions (85) and they have pharmacological actions other than just 
inhibiting cholesterol synthesis, statins may not serve as a useful tool to investigate the 
mechanism by which cholesterol regulate Ca2+ entry in PAECs. However, the antioxidant 
effects of statins that increase NO bioavailability in pulmonary endothelium during CH-
induced PH suggest their potential role in preventing cholesterol oxidation (76, 88, 100). 
Considering the fact that ROS are also associated with the development of atherosclerosis, 
it is possible that oxidized cholesterol may contribute to impaired endothelial Ca2+ entry in 
these diseases. 
 
Physiological significance of current studies 
The current studies advance our mechanistic understanding of impaired Ca2+ entry in 
PAECs as a key feature of endothelial dysfunction during CH-induced PH. Since agonist-
induced Ca2+ entry, SOCE, and depolarization-induced Ca2+ entry are important in 
mediating pulmonary endothelial [Ca2+]i, restoring Ca
2+ influx in PAECs may help increase 
endothelial Ca2+-dependent vasodilation in pulmonary arteries following CH. The 
discovery that membrane cholesterol is important in mediating these Ca2+ entry pathways 
thus provides membrane cholesterol as a potential new therapeutic target in treating CH-
induced PH.  
Our current studies also add potential insights in understanding the mechanisms of 
acute hypoxic pulmonary vasoconstriction (HPV). Pulmonary arteries constrict in response 
to acute hypoxia, which is responsible for limiting the ventilation-perfusion ratio mismatch 
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during localized alveolar hypoxia. One of the hypothesized mechanisms suggests that HPV 
is achieved primarily through activation of voltage-dependent L-type Ca2+ channels in 
VSMCs in response to membrane depolarization as a result of inhibition of KV channels 
by hypoxia (5, 81, 141). However, studies using isolated perfused lungs and isolated 
pulmonary arteries show that HPV is not very sensitive to blockers of L-type Ca2+ channels 
(110, 137). In addition, because VSMCs are located in pulmonary arterioles and arteries 
that are rather remote from the capillaries adjacent to alveoli, the connection between 
oxygen sensing in areas of gas exchange and vasoconstriction remained undefined. Studies 
from Kuebler group in recent years filled this gap between oxygen sensor and effector in 
HPV (50, 135). In their proposed mechanism of HPV, alveolar capillaries sense hypoxia 
and conducts the depolarization response retrogradely along the endothelial cell layer 
through connexin-40 gap junctions to upstream arterioles and large arteries. Membrane 
depolarization activates T-type VGCCs and increases production of arachidonic acid (AA) 
metabolites epoxyeicosatrienoic acids (EETs) in a Ca2+-dependent manner. EETs then 
diffuse to VSMC and cause vasoconstriction potentially through activation of TRPC6 and 
TPRV4. In CH-induced PH, HPV is greatly reduced (132, 143, 150). Given the importance 
of endothelial T-type VGCCs in HPV, our observations that CH impairs T-type channel-
mediated Ca2+ entry by reducing membrane cholesterol suggest that the loss of T-type 
channel function may be one of causes to diminished HPV in CH-induced PH (148). 
In addition to hypoxia, other physiological stimulus may also cause membrane 
depolarization and activate T-type channel. Shear stress, for example, induces the 
production of ATP in endothelial cells (3, 67), which may serve as an autocrine factor that 
depolarizes endothelial cells. In addition, shear stress may initiate SOCE though increased 
147 
 
IP3 production (105). Since store depletion leads to Ca
2+ entry through T-type channels 
(145) in PMVECs, shear stress could potentially activate T-type channels indirectly. 
Another source of endothelial depolarizing stimuli is the membrane depolarization of 
VSMC. This is achieved by direct electrical communication between these two type of 
cells through gap junctions (2). In pulmonary arteries, depolarized VSMC may activate T-
type channels on endothelial cells and Ca2+-induced endothelium-dependent 
vasorelaxation to relieve the tone. However, in spite of increased shear stress (133) and 
PASMC depolarization (16) after CH, these potential mechanisms of vasodilation could be 
impaired in pulmonary arteries due to reduced cholesterol-mediated T-type channel 
function. 
Cholesterol is rarely considered “good” in many diseases (35, 91), especially in 
atherosclerosis (57). Adding cholesterol to endothelial cells from aorta reduces both ATP-
induced Ca2+ entry and SOCE, along with flow-induced NO production (4), which is the 
opposite of what we found in PAECs. Our findings suggest that the contribution of 
membrane cholesterol to endothelial dysfunction during development of various vascular 
diseases may be different between the pulmonary circulation and systemic vasculature.  
 
Limitations of studies 
In our current studies, isolated native PAECs and cultured PMVECs were investigated. 
PAECs were isolated in normoxic conditions, which removed the hypoxic stimulus to cells 
from CH animals and enables us to study effects of CH independent of acute hypoxic 
influences. Although these changes may not affect expression or synthesis of ion channels, 
proteins, and lipids, they do have potential impact to trafficking and compartmentation of 
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these components involved in the endothelial Ca2+ entry. It should also be noted that by 
studying cells, the effect of many physiological stimuli, such as stretch of pulmonary 
arteries associated with lung movement during breathing and vasoactive compounds 
released by erythrocytes, were not included, which may also influence the endothelial Ca2+ 
influx.  
We used fura-2-AM as a fluorescent Ca2+ indicator to measure endothelial Ca2+ influx. 
The ratiometric measurement of fura-2 only provides information in global change of 
[Ca2+]i without indication of localized Ca
2+ events, which may be important in regulating 
the production of EDHF through activation of small and intermediate conductance Ca2+-
activated K+ channels (68). Thus, how a change of membrane cholesterol would affect Ca2+ 
responses in caveolae or areas close to lipid rafts is unknown. Although Mn2+ quenching 
technique is a clean approach in measuring Ca2+ entry, limited information of kinetics of 
stimulated Ca2+ influx was acquired. Additionally, all cells were stimulated in the absence 
of extracellular Ca2+ for a period of time, and Ca2+ responses were examined afterwards. 
This approach certainly did not mimic native agonist-induced Ca2+ influx, which happens 
immediately upon stimulation and store depletion. Overall, these limitations of approaches 
should be considered when interpreting findings of current studies.  
 
Summary 
To summarize, membrane cholesterol contributes to the normal function of many Ca2+ 
influx pathways in PAECs. The stimulation with an agonist like ATP not only initiates 
SOCE by activating Orai1 through clustered STIM1 in response to ER Ca2+ store depletion, 
but also causes membrane depolarization and subsequent Ca2+ entry via T-type VGCCs. 
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These agonist-induced Ca2+ influx components become inactive following CH due to 
reduced membrane cholesterol levels and the loss of functional regulation of ion channels. 
Impaired cholesterol-dependent endothelial Ca2+ influx may contribute to decreased 
production and release of endothelium-derived vasodilators and anti-mitogenic factors 
following CH. These features of endothelial dysfunction may additionally contribute to 
increased vasoconstrictor reactivity, arterial smooth muscle mitogenesis, and development 
of PH.  
Challenges of future studies are to identify the potential contribution of ROS to 
decreased endothelial cholesterol following CH, either through direct cholesterol oxidation 
or impaired sterol trafficking, and the potential impact of these responses to trafficking and 
surface expression of Cav-1 and Ca2+ channels including TRPC1 and Orai1. Additionally, 
it is important to explore the effect of CH on ER STIM1 clustering in pulmonary artery 
endothelium. Finally, the physiological effect of cholesterol supplementation on NO 
production and endothelium-mediated vasodilation in pulmonary arteries after CH 
exposure remains to be identified.  
To conclude, elevated cellular membrane cholesterol has been linked to many 
diseases (35, 57, 91). In contrast, CH-induced PH appears to be associated with 
diminished membrane cholesterol in PAECs. Our current studies clearly establish a 
prominent role of membrane cholesterol in the regulation of agonist-induced Ca2+ entry in 
PAECs. These studies also support a role for reduced membrane cholesterol in impaired 
Orai1-mediated SOCE following CH. These findings may provide a mechanistic basis to 
explain CH-induced diminution of endothelial Ca2+ influx and associated endothelial 
dysfunction that is central to the pathogenesis of pulmonary hypertension.  
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